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Abstract 
Introduction 
lodinated contrast media have been in use in medicine since 1929. 
The first media were extremely toxic. For instance extravasation would cause 
extensive tissue necrosis, anaphylaxis and death were significant risks. The history of 
the development of intravascular contrast agents is one of increasing the degree of 
opacification obtainable and decreasing the risk of adverse reactions. 
Currently it is believed that nonionic contrast media are safer and cause fewer 
reactions than ionic ones, however reactions still occur. 
One aspect that has not received much attention has been gender differences. 
Lang et.al. (1995) commented females had higher risk of anaphylactoid reactions 
caused by radiologic contrast media injections. If female patients do have more risk 
to contrast media reactions, then we should take precautions related to the patients' 
gender. 
Therefore, this research project serves to study in the Diagnostic Radiology and 
Organ Imaging Department, Prince of Wales Hospital, the influence of gender on 
radiologic intravenous contrast reactions. 
Unfortunately it is impossible to study just the single variable of gender, we have to 
consider the dose as well as the nature of the contrast being administered. Practical 
and ethical considerations demand that some patients to be given steroid 
premedication to modify risks of anaphylaxis. This is bound to alter reactions and 
adds yet a further variable. Finally we must ensure that the quality of the films 
produced is of accepted standard. 
Methodology 
This was a prospective double-blind study. From September 1999 to October 2000, 
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796 consecutive patients who had intravenous urography in our department were 
entered into this study. The exclusion cr i te r iaexamina t ions that requested extra 
dose of contrast media; patients with only one opacified kidney; patients whose body 
weight could not be obtained; and patients not available for reporting the presence or 
absence of delayed reactions. 
Patients included were given either a nonionic contrast medium: lopamidol 300 
mg/ml (lopamiro 300), or an ionic contrast containing sodium & meglumine 
Amidotrizoate 325 mg/ml (Urovison 58%). The choice of contrast media was 
determined by the radiologist who gave the contrast, according to professional 
judgement in choosing safe and effective contrast medium for that particular patient. 
The choice of contrast media could not be randomized due to ethical reason. Patients 
who had nonionic lopamiro were randomly assigned to have either one of three dose, 
namely 300 mg I/Kg, 390 mg I/Kg, and 450 mg I/Kg of body weight. Dose rates 
were adjusted to be 292.5 mg I/Kg, 390 mg I/Kg and 455 mg I/Kg respectively for 
ionic Urovison due to different concentration in preparations. 
Patients' medical and contrast media histories, injection conditions for that particular 
exam, absence or presence and details of immediate reactions were recorded. After 
48 hours post-injection, a telephone interview was conducted for each patient to 
establish the absence or presence and details of delayed reactions. 
Results 
1. Overall, 274 (34%) of patients suffered immediate reactions only. 110 (14%) had 
delayed reactions only, while another 174 (22%) had both immediate and 
delayed reactions, leaving 238 (30%) without any reactions. 
2. Common immediate reactions were heat sensation (49.2%), nausea (5.3%), 
strange taste in the mouth (4.0%), and rash (2.9%), with no significant gender 
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differences. 
Common delayed reactions were fatigue (19.5%), itching (9.8%), rash (8.9%), 
gastrointestinal upset (8.7%), dizziness (6.5%), and joint pain (6.5%). Females 
experienced significantly more than males in all reactions. Most delayed 
reactions (94.1%) occurred within 48 hours after injection. 
3. Gender difference of reactions 
54% of male and 56% of female patients suffered immediate reactions 
(p=0.695). 30% of male and 43% of female patients suffered delayed 
reactions(p=0.019). 
4. Gender difference with difference dose of contrast media 
With 300 mgl/Kg of nonionic contrast, or 292.5 mgl/Kg of ionic contrast, 69% 
of male and 66% of female patients experienced either immediate, delayed, or 
both kinds of reactions (p=0.595). At 390 mgl/Kg, 69% of male and 73% of 
female had reactions (p=0.392). With 450 mgl/Kg or 455 mgl/Kg, 67% of male 
and 78% of female had reactions (p=0.021). 
5. Difference between different contrast media 
Urovison, the ionic contrast, caused significantly more immediate reactions 
(70%) than the nonionic lopamiro (43%) (p=0.000). However, nonionic 
lopamiro caused significantly more delayed reactions (40%) than ionic Urovison 
(31%) (p=0.006). 
6. Logistic regression revealed that the significant risk factor for immediate 
reactions were age (p=0.0014), and the type of contrast media used (p=0.000). 
Using ionic Urovison would expose paiients to greater risk than nonionic 
lopamiro. The significant risk factor for delayed reactions were the female 
gender, (p=0.0159), and patients who had steroid cover (patients with 
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preexisting risks for contrast reactions) (p=0.000). 
Conclusions 
1. Females demonstrated lower tolerance level in relation to dose. 
2. Different contrast media 
The ionic medium caused significantly more immediate reactions than the 
nonionic medium. There was no significant difference between two kinds of 
contrast media with regard to delayed reactions. 
The observation that nonionic medium caused more delayed reactions was due 
to the fact that all high-risk patients, who had significantly more delayed 
reactions, had nonionic contrast media. 
3. Nonionic medium caused significantly more immediate reactions in female 
patients. Female patients suffered significantly more delayed reactions for both 
kinds of contrast media. 
























2.最常見的即時反應是感到很熱〈49 • 2%〉、想吐〈5.3%〉、口腔裡有怪 
味〈4.0%〉、和出疼〈2 .9%〉’性別對這些症狀是沒有影響的。 




0 • 695〉° 30%的男性和43%的女性感到延遲反應〈p = 0 • 019〉。 
4.病人性別及劑量對反應頻率的影響 
在使用低滲造影劑、每公斤體重300毫克碘、或高滲造影劑Urovison每公斤2 
92 • 5毫克碘的劑量時，69%的男性和66%的女性發生即時、延遲、或兩種 
反應都有〈P 二 
0 • 595〉。每公斤390毫克碘，69%男性和73%女性發生反應〈p = 
0 • 392〉。每公斤450或455毫克碘，67%男性和78%女性發生反應〈p = 
0 • 021 > ° 
5.不同種類的造影劑 
高滲造影劑比低滲造影劑導致更多即時反應〈P = 
0 • 000〉。而低滲造影劑比高滲造影劑導致更多延遲反應〈P = 0 • 006〉。 
即時反應的主要因素有年齡較小〈P 二 0 . 001〉和接受高滲造影劑〈P 二 
0 - 000)。延遲反應主要因素是女性〈P = 
0 • 016〉和服用類固醇的病人〈已知對造影劑反應高危的病人〉〈P = 
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1 Introduction 
1.1 History of iodinated contrast media 
The first intentional use of radiological contrast medium was achieved in January 
1896’ two months after discovery of X-rays -r « November 1895, when calcium 
carbonate emulsion was injected into the brachial artery of the severed arm of a 
cadaver. In 1917, Cameron published that oral and intravenous sodium iodide could 
produce a urinary cystogram opaque to X-rays. The first paper on intravenous 
urography with intravenous sodium iodide was published in 1923. This paper 
established the potential of iodine as an intravascular agent, but the problem was how 
to package large amount of toxic iodine atom into a safe, non-toxic molecule. 
Excellent quality diagnostic intravenous urographs were obtained using 'Selectan 
Neutral，，a nonionic, monoiodinated pyridone molecule, and later with the less toxic, 
but more soluble, 'Uroselectan' (1). In 1929,Uroselectan (sodium 5-iodo-2-pyridone-
N-acetate) was introduced, allowing the demonstrated of the urinary system, a great 
breakthrough in its time (2). 
The subsequent development of contrast media was first due to the need of 
improving opacification quality, then closely related to safety in clinical 
administration. 
In the early 1930，s, Uroselectan was superseded by two improved iodinated pyridone 
products, iodoxyl (Uroselectan B) and iodopyracet (Diodone), both containing two 
atoms of iodine. The use of an iodine substituted benzene ring was introduced in 
1933, but the agent, sodium monoiodophippurate, contained only one atom of iodine, 
and was toxic. In the mid 1950s, tri-iodinated benzoic acids (diatrizoic and 
iothalamic acids), with three iodine and two acetylamino groups attached to one 
benzene ring, were introduced into clinical practice. These contrast media were also 
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known as Hypaque, Urographin and Conray. Since these agents are much safer to use 
than their precursors, they become the standard contrast media of choice for the next 
25 years. However, they are very hyperosmolar, which greatly increases toxicity (2). 
High osmolality causes changes in cellular function and/or release of various 
vasoactive substances from the cells. Vasoactive substances may cause various 
pseudoallergic symptoms (3), e.g. anaphylactoiH reactions. 
Contrast media based on iodine have been the leading media since the 1920s because 
they have produced fewer adverse biological effects than other elements (3). 
Almen postulated in 1969 the idea that low osmolar, nonionic contrast media may be 
less toxic. The first one, Metrizamide, was available from the 1970s, mainly as a 
myelographic agent. However Metrizamide was unstable in solution, the powder had 
to be dissolved immediately before injection (2), and this limited its usefulness. 
Nonionic contrast media are better tolerated because of reduced hyperosmolality, 
absence of ionizing carboxyl groups and various lipophilic groups, and presence of 
hydrophilic hydroxyl groups. Lipophilic parts of the molecule may cause changes in 
cellular function and/or the release of vasoactive substances (3). 
In mid-1980s the second-generation low-osmolar contrast media e.g. nonionic 
lohexol (Omnipaque), iopamidol (Niopam), and ionic ioxaglate (Hexabrix) were 
marketed and are still among the contrast media of choice today (2). 
In the 1980s and 1990s there has been ongoing development of nonionic dimers. The 
advantage of nonionic dimers was low toxicity, due to completely substituted tri-
iodinated benzene rings, absence of carboxyl groups, hydroxyl groups are evenly 
distributed around the molecule, and iosotonicity to plasma. The nonionic dimers 
available today are iotrolan and iodixanol (Visipaque) (3). 
There were many reactions, including death and the requirement for safer agents has 
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been, to a large extent, met by the designers and manufacturers of contrast agents. 
The risk of death is now much lower, the range is between 1 in 40,000 to 1 in 
100,000; and in recent studies the mortality rate is 1 in 169,000 injections, which is 
equal for both ionic and nonionic contrast media. However, reactions are still 
common (for immediate reactions, 5%-12%, and 27% for delayed reactions) (4,5). 
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1.2 Classification of contrast media reactions 
The previous section pointed out that the need for development of modem contrast 
media was mainly due to increasing demand of safety to patients, that is, to reduce 
reactions due to administration of contrast media. There were many types of 
reactions of contrast media, and many ways to classify them. One method of 
classification is by 
Degree of severity: 1. Serious, life threatening; 2. Intermediate, need treatment and 
may need admission; 3. Minor, perhaps uncomfortable but will not need treatment; 
and 4. expected effects. 
Minor reactions Intermediate r eac t i on s iMa j o r reactions 
Nausea Faintness Severe collapse 
Vomiting (limited) Severe vomiting Loss of consciousness 
Limited urticaria Extensive urticaria Cardiac arrest 
她 pain Edema of face/glottis Arrhythmias 
(Angioneurotic oedema) 
Sneezing Bronchospasm Pulmonary edema 





Table 1 Classification of acute adverse reactions according to Mikkonen et.al. (6) 
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Minor immediate reactions Minor aeiayed reactions 
Cough Arm pain “ 
Heat sensation Asthma ‘ 
Itching “ Difficulty in urination 
Nausea Dizziness 
Rash (Urticaria) Fatigue 
Strange taste in throat Gastrointestinal upset 
Vomit Headache “ 
Yawning &/or sneezing Itching 
Joint pain 
Swelling and/or of the salivary glands 
Heat sensation 
Table 2 Minor immediate reactions according to Kropelln et.al. (7), and minor delayed 
reactions according to Davies (8). 
Heat sensation and metallic taste in the mouth are very common reactions, which are 
usually not alarming to the patients (or the radiological staff). These are called 
expected effects. 
The list above is not exhaustive, as is true of many lists in the literatue, and this is 
especially true for the minor reactions. 
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1.3 Mechanisms of contrast media reactions 
As already stated the mechanisms of contrast media reactions are still not clear. The 
following is a brief description of current wisdom. It serves to show the many 
pathways by which reactions may be activated. The fact that several different 
pathways can be activated at one time creates a confusing complexity of responses. 
1.3.1 Fatality following injection of contrast media 
It was proposed that all contrast media deaths might be related to the effect of the 
contrast media on the central nervous system. (9). 
1.3.2 Mechanism of severe reactions 
Histamine release and mast cell triggering are related to severe reactions. An IgE-
related mechanism is strongly suspected (10). Complement activation, coagulation 
system activation, prekallikrein transformation ？ind generation of bradykinin may be 
factors (11). 
1.3.3 Cardiac arrhythmia and arrest 
Bradycardia or cardiac arrest may be caused by activation of the parasympathetic 
system and act through the hypothalamus (12). 
1-3.4 Vagal reaction 
A patient having vagal reaction after contrast injection becomes confused, 
apprehensive, diaphoretic, vasodilatation, and may proceed to cardiac arrest if 
untreated (13). 
1.3.5 Hypotension 
A patient with systolic blood pressure less than 90 mm Hg is hopothensive. 
Hypotensive reactions may be isolated or may be associated with other 
manifestations, such as airway edema and bronchospasm (14). Hypotension is caused 
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by vasodilatation. The mechanisms underlying the vasodilator effects of contrast 
media are not fully understood and are considered to be multifactorial. Contributing 
factors include osmolar strength, direct effects on ions fluxes, and possibly viscosity. 
Vasodilatation is less with dimeric agents (15). It has been suggested that contrast 
media cause large and rapid expansion in the plasma volume, causing a peripheral 
vasodilatation with an associated hypotension (16). 
1.3.6 Hypertensive crises 
Hypertensive crises may occur in patients with a history of hypertension and cardiac 
disease, in which case angina may also be present. Patients with hypertensive 
reactions may complain of a sudden severe headache. Other possible manifestations 
include nausea, vomiting and altered mental status (14). 
1.3.7 Angina 
Patients with angina typically present with retrosternal discomfort that is moderate in 
severity. These patients usually have a history of cardiac disease and often have had 
similar episodes previously (14). 
1.3.8 Respiratory decompensation 
There are several causes of respiratory decompensation after contrast media 
injection. These include upper airway and laryngeal edema, bronchospasm, 
pulmonary edema, and anxiety. (14). 
A small degree of bronchospasm occurs with all contrast media use as a result of the 
effect of the parasympathetic portion of the autonomic system affecting the bronchi. 
This may become severe in asthmatics (12). 
1.3.9 Seizures 
Seizures may result from hypoxia in severely hypotensive patients or in patients with 
respiratory insufficiency. Neurogenic seizures occur in patients whose blood-brain 
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barrier has been disrupted, such as in patients with central nervous system neoplasms 
(14). 
1.3.10 Cutaneous reactions 
Urticarical skin reactions (hives) are anaphylactoid reactions in which patients 
develop raised focal areas of skin and subcutaneous tissue swelling. Hives may be 
single or multiple. They can occur anyway on the body, although they seem to be 
more common on the face, neck and chest. They are usually pruritic. No treatment is 
needed for most patients (14). 
1-3.11 Other minor reactions 
Many minor reactions such as nausea, vomiting are considered to be functions of the 
hypertonicity of contrast media (17). 
1.3.12 Mechanism of delayed reactions 
The exact pathogenesis of delayed reactions is still unclear. There is increasing 
evidence that a significant proportion of the reactions is T-cell mediated (18). 
1.3.13 Iodide mumps 
The etiology of iodide mumps remains unclear. It has been shown that small but 
significant quantities of free iodide are present in preparations of contrast media. 
Salivary glands are able to trap substantial amounts of iodide from plasma and 
concentrate it in the ductal systems, leading to ductal cell swelling and at least partial 
obstruction of the ducts with consequent inflammatory swelling (19). 
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1.4 The multi-factorial contrast media reactions 
The need of nonionic contrast media was due to adverse reactions to ionic contrast 
media. Nonionic contrast media was considered much safer, caused much less 
frequent and less severe reactions than the ionic agents. Dawson and Hemingway 
(1987) suggested that larger doses of contrast media caused more reactions than 
smaller doses (20). Also Lang et.al. (1995) commented that female patients had more 
anaphylactoid reactions than male patients (211 
The large number of reactions to contrast media can be classified into idiosyncratic 
and chemotoxic, immediate or delayed, each class of reactions can be further 
categorized by degree of severity, which ranged from minor to life threatening. In 
fact there are no simple way to classify all common contrast media reactions. Up to 
now we do not fully understand the mechanisms and factors leading to most of these 
symptoms. 
Adding up all the factors, it becomes a confusing mosaic of intertwining causes and 
effects of reactions to iodinated contrast media. 
Therefore, in order to study reactions to contrast media, we need a systematic method 
to investigate the effects of types of contrast media, patients' genders, dose of 
contrast media, and patterns of reactions. 
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1.5 Contrast reactions and patient gender 
One aspect of reactions that has not achieved much attention has been gender 
differences in response to contrast reactions. 
Lang et.al. (1995) (21) commented females had higher risk of anaphylactoid 
reactions caused by radiologic contrast media injections. There are only two studies 
dedicated to risk of anaphylactoid reactions to contrast media with respect to gender 
(21, 22). 
Despite，or may be because of, the lack of meaningful data there is no attempt to 
recommend that males and females be treated differently (23, 24). However if female 
patients really do have more risk to contrast media reactions, then we should take 
precautions related to the patients' gender. 
Lang et.al. (1995) (21) suggested females were more susceptible to contrast media 
reactions due to their small size related to the male, in particular their vascular 
capacity, which would result in a greater relative concentration of contrast media for 
a given dose. This is based on a general observation that there is 95 ml of blood per 
kilogram of body weight in a man, which is 42% more than a woman who has only 
67 ml of blood per Kilogram (25). 
When contrast media injection is concerned, factors affecting contrast reactions are 
1 • Patient's gender, either male or female, which we cannot control 
2. Nature of reactions, either idiosyncratic or physiochemotoxic, which we cannot 
control (4，5) 
3. Dose of contrast media, which we can manipulate within the limitation imposed 
by necessary contrast enhancement. 
T.herefore’ this research project serves to study in the Diagnostic Radiology and 
Organ Imaging Department, Prince of Wales Hospital, the influence of gender on 
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radiologic intravenous contrast reactions. 
1.6 Patient profile 
Gender Mean age Mean Steroid contrast Dose N Immediate Delayed 
(years) weight covered media reactions reactions 
(Kg) (N) (N) 
Male 56.8 “ ^ Nonionic 1 2 3 6 1 2 ~ 
N=447 SD= SD= N=69 N=69 7 11 
15.4 10.9 8 1 2 ^ 
No Nonionic i 5 5 " 21 \5 
N=378 N=159 2 ^ Y \ 1 3 ^ 
^'54 15 
i ^ 52 Y\ 
N=219 ~ ~ 2 7 4 « 20^ 
^ 7 7 s i 1 6 ^ 
Female 53.04 56.08 ^ Nonionic 1 “ ~ 16 1 5 ~ 
N=349 SD= SD= N=107 N=107 一:18 1 % ^ 
15.34 9.56 S ^ 
No Nonionic 1 4 2 ^ 13 
N=242 N=107 2 3 5 15 1 0 ^ 
30 14 n ^ 
Ionic ~ i 4 5 ^ 15 
、 N=135 2 45 32 17 
~ 3 ~ 4 5 ^ 19 
U  
Table 3 Patients in this study 
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2 Hypotheses 
1. Females show a lower tolerance level than males when given the same amount 
of contrast medium. 
2. Females are more likely to suffer contrast reactions than males irrespective of 
dose. 
3. There is a difference in reactions between ionic and nonionic contrast media. 
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3 Objectives 
The objectives of this study are 
1 - To investigate in intravenous urography (r.^J) the gender difference of reactions 
in relationship to the dose of contrast media. 
2. To see if the dose of contrast media, within the currently accepted ranged of 
doses, has any effect on the frequency of contrast reactions. 
3. To see if there is a difference in the response to ionic and nonionic intravenous 
contrast media. 
4. To see if there were gender differences in response to contrast media. 
5. To see if there are differences in the nature of the reactions to contrast media. 
6. To ensure that the ranges of contrast dose used produced images of diagnostic 
quality and for the proposes of this study of similar quality. 
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4 Clinical implications 
The clinical implications for this study are that should there be any differences 
discovered it may be possible to devise more specific dose protocols that would 
ensure diagnostic quality images and minimize uncomfortable patient reactions, and 
maximize cost effectiveness, by avoiding delays and interventions made necessary 




This was a double blind, prospective study. Consecutive patients who came for an 
intravenous urography (IVU) in our department between 6 September 1999 and 24 
November 2000 were recruited into this study. 
The equipment used were Siemens MP512 and Philips DSI 76 SCP System. Both 
were fluoroscopic systems without tomograpnic lunction. 
Patients were divided into 12 groups (Table 4). Patients were either male or female, 
given either a nonionic contrast medium lopamidol 300 mg/ml (lopamiro 300), or an 
ionic one containing sodium & meglumine Amidotrizoate 325 mg/ml (Urovison 
58%), and had one of the three dose levels. The dose levels administered were 
assigned by randomization tables (26). 
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5.1 Patient groups 
Dose level notation Dose 1 Dose 2 Dose 3 
Contrast media lopamiro Urovison lopamiro Urovison lopamiro Urovison 
Type Nonionic Ionic Nonionic Ionic Nonionic Ionic 
Preparation ^ ^ ^ 300 ^ 
(mgl/ml) 
Iodine content to ^ m m ^ 
patient (mg I/Kg) 
Dose to patient LO U 12 LS \A^ 
(ml/Kg) 
Gender $ 竿 S 竿 $ 罕 $ 罕 S 罕 S 罕 
Patient group 1 2 3 4 5 6 7 8 9 1 0 5 1 
Table 4 Patient grouping and contrast media dose assignment 
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5.2 Choice of contrast media 
I 
1. As nonionic and ionic contrast media are widely used for intravenous urography 
it was necessary to include both agents in the study. To represent nonionic 
contrast media lopamiro was used. Urovison represented ionic contrast media. 
The reason being that they are commonly used and are the standard agents 
selected by this department. 
2. The choice of contrast media was determined by the radiologist who gave the 
contrast. The decision was made according to professional judgement in 
choosing a safe and effective contrast medium for that particular patient. 
3. The decision would be aided by considering the following criteria, which were 
obtained by interviewing patients before injection. Information obtained was: 
> Patient's past experience with contrast injection and appropriate medical 
history 
> Whether the patient had a high risk to contrast reactions by virtue of age, 
allergy and asthma, medications, and prior reactions to contrast media (4, 
27) 
> Whether steroid prophylaxis was prescribed and taken (28) 




5.3 Amount of contrast media 
From the literature, 1 ml per kilogram body weight of 300 mgl/ml nonionic contrast 
media was recommended, though the optimal dose was 1.5 ml/Kg (29). Dominik 
et.al. wrote that ‘an increase of the dosage resulted in a statistically significant 
improvement of the quality of the radiographic visualization...due to economic 
consideration at the present, a dose of 1.0 ml/Kg (300 mg I/ml) is viewed as adequate 
...from a purely medical point of view, the injection of 1.5 ml of nonionic CM/Kg 
body weight is considered optimal' (29) . This gives an accepted dose range of 300 
mgl per Kg body weight to 450 mgl per Kg body weight. For the propose of this 
study three dose levels were used. 
Dose level notation Dose 1 Dose 2 Dose 3 
Contrast media lopamiro Urovison lopamiro Urovison lopamiro Urovison 
t 
Type Nonionic Ionic Nonionic Ionic~ Nonionic ~Ionic~~ 
Preparation 300 325 ^ ^ ^ ^ 
(mgl/ml) 
Dose to patient 1.0 09 U \2 f s \ A ^ 
(ml/Kg) 
Iodine content to 300 292.5 ^ ^ ^ " " " 
patient (mg I/Kg) 
Tables The amount of contrast media given to patients, expressed in doses 1’ 2 and 3 
respectively, dose (ml/Kg) and iodine content (mgl/Kg) of body weight 
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5.4 Practical points 
1. Patients' height and body weight were measured by the radiographer. 
2. Dose level was assigned to each patient by using randomization tables (26). 
3. Warmed contrast medium (30) was injected in a fast bolus (31). 
4. Blood pressure and pulse were measured both before injection and 5 minutes 
post-injection, to assess any changes in blood pressure and patient's anxiety 
level (32). 
5. The presence or absence of immediate reactions was observed and recorded by 
nurses. 
6. The presence or absence of delayed reactions was obtained by phone interview 
after 48 hours post-injection, because most delayed reactions occur within 2 
days after injection (33). A single interviewer conversed with the patients, when 
the latter described their symptoms. Symptoms which corresponded to those of 
known delayed reactions (8) were recordcJ.-
I 
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5.5 Double blindness of the study 
1. Patients did not know how much or what kind of contrast media was given. 
2. Nurses were responsible for observing and recording immediate reactions. They 
knew the amount of contrast media given to patients. However, they did not 
know patients' body weight. Therefore the nurses did not know how much 
contrast was given per unit weight. ‘ 
3. Radiologists graded quality of IVU films. They knew the amount of contrast 
media given to patients. They did not know patients' body weight. 
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5.6 Inclusion/exclusion criteria 
1 Inclusion 
Each intravenous urography exam was treated as an individual case. Multiple 
entries for the same patient were allowed. Because one major risk of contrast 
media reactions was previous reactions to contrast media (34)，it would not be 
appropriate to exclude a second exam of the same patient. Otherwise the 
frequency of reactions related to previous contrast media reactions would be 
underestimated. In this series of 796 patients, 287 patients (36.1%) had previous 
experience of intravenous contrast media injection. 
Between 6 September 1999 and 24 November 2000’ 1306 patients attended our 
department for intravenous urography exam. One hundred patients were 
rebooked or cancelled. Out of the 1206 patients who had the exam, 136 patients 
were excluded by the exclusion criteria (please see below), leaving 1070 
patients (89% of 1206). Only 796 (74.4% of 1070 patients) were interviewed 
successfully for delayed reactions and subsequently analyzed. 
2 Exclusion 
2.1 Pregnant patients were excluded (35).‘ 
2.2 Patients who needed additional contrast media for adequate visualization 
(in this series 36 patients, 3 % of total) 
2.3 Patients with only one opacified kidney were excluded. It was because 
quality assessment could not be done with the same quality contrast 
comparator (please see Quality Control, P.26), since compensation of the 
residue kidney might occur in a single functioning kidney (in this series, 
69 patients, 5.7 %). 
2.4 Patients whose body weight could not be obtained. Body weight and 
21 ‘ 
height were measured by the radiographer prior to exam using an ordinary 
electronic scale. Some patients, e.g. paraplegic patient, could not be 
weighed and were therefore excluded. These patients could not be 
randomly assigned a dose (in this series, 26 patients, 2.2%). 
2.5 Patients whom the radiologist decided not to randomize due to various 
considerations (e.g. when examining an infant, a fixed dose of 10-15 ml of 
nonionic contrast media was used regardless of body weight (22), and a 
nonionic dimer, lodixional, might be used instead of the nonionic 
i 
monomer lopamidol; in this series 4 patients, 0.3%). 
2.6 One patients was excluded because the 12-minute film was not taken 
(please see Results, P.53) 
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5.7 Patient preparation 
Patient preparation was according to the standard regime: 
1 28-day rule ofLMP (Last menstrual period) was observed (36) 
2 Steroid cover for high risk patients (4, 27, 28, 37) 
2.1 Regime of steroid cover in Diagnostic Radiology & Organ Imaging 
Department, Prince of Wales Hospital (Please see Appendix 1) 
3 Bowel preparation (38) 
3.1 Low residue diet three days prior to examination 
3.2 Aperient (two Ducolax tablets) for two concessive nights prior to 
examination ‘ 
3.3 Fast for at least four hours prior to examination 




5.7.1 Modification of department protocol for IVU 
Risk factors for patients that required steroid cover are listed in our department's 
guidelines. These risk factors are known iodine allergy, previous serious contrast 
reactions (anaphylactic shock, severe bronchospasm, cardio-respiratory arrest), 
patient over 60 years old with heart disease, and patients with severe asthma, atopic 
eczema, hay fever, or allergic rhinitis (Appendix 1). 
The referring physicians indicated on the request forms if the patient presented with 
any of the above risk factors, and steroid cover was prescribed. When patients 
arrived on the day of exam, the nurse or radiographer questioned the patients for 
history of allergy and status of steroid cover. Immediately before contrast 
administration, the radiologist who gave the injection would repeat the questions and 
make sure the patient was properly covered if there was such a need. 
In this study, all the questions and answers were recorded on a standard form 
(Appendix 2). All the other procedures remained unchanged. The written form 
proved to be an effective way of communication, which is now being used as 
standard in ail the rooms in the department that intravenous contrast media injection 
is carried out. 
Before the study, the radiologist determined the amount of contrast media to patient. 
Frequently 50 ml of contrast media, either nonionic or ionic, was given. For bigger 
built patients 75 ml or 100 ml was used. Patients' body weight was not measured. 
Taking the average body weight of males arc。: Kg and that of females are 56 Kg 
(Please see Results), the effective doses for males were from 0.8 ml of contrast media 
per kilogram of body weight to 1.5 ml/Kg, while the doses for females were from 0.9 
to 1.8 ml/Kg respectively. 
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5.8 Data acquisition 
Three data sheets were used. 
> 
1. The first data sheet recorded patients' medical and contrast media histories. 
(Appendix 2) 
2. The second data sheet recorded injection conditions for that particular exam, e.g. 
amount of contrast media used, and absence or presence and details of 
immediate reactions (Appendix 3). 
3. After 48 hours post-injection, a telephone interview was conducted for each 
patient to establish the absence or presence and details of delayed reactions. Data 
were recorded on the third data sheet (Appendix 4). 
The first and second data sheets were printed back to back. The third sheet was 
printed separately. Labels of patients' name pnH jHpntities were used on each piece of 




5.9 Quality control 
Because this study manipulated dose of contrast media, a means of quality control 
was mandatory to ensure that the films were within an acceptable range of diagnostic 





5.9.1 Gross results of quality control 
Out of the 796 intravenous urography exams, 95.7% (762 films) were evaluated. 96% 
(732 films) scored 2 marks or above, that is, of diagnostic opacification quality. 
Frequency of quality score N=762 




I 200 - ^ n 
① ：、： 、 ： 
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100 - r ~ | � 76 
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Score 
Figure 1 Frequency of quality score 
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Score Description Number % 
0 Non-diagnostic U 
1 Barely diagnostic 19 ^ 
2 Less than adequate U4 
3 Adequate 
4 Good ^ ^ 
5 Excellent 76 ^ 
Not available for grading M ^ 
Total ^ 
Table 6 Frequency of quality score 
The quality control exercise and its results proved that the whole study was 
conducted in such a manner that image quality was not sacrificed by manipulation of 
contrast media dose to patients. 
For detailed results of image quality please refer to Discussion. 
I 
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5.10 Data management and analysis 
All data were entered into and managed by Microsoft Access, and analyzed by SPSS 
Version 9 for Windows. 
Chi square tests were used to decide on significance of results. Spearman's 
correlation coefficient was calculated whenever there was the need to establish 
relationship between entities, e.g. between dose and opacification quality. Kruskal-
Wallis Test compared quality score on contrast media. 
Only non-parametric tests were employed because the results and their affecting 
factors were presented as nominal or ordinal data (e.g. presence or absence of 
reactions, patients' gender, and dose rates 1,2, and 3, etc.) 
Independent T-test was used when analyzing patients' age, since the data were 
normally distributed. Logistic regression was used to decide which factors most 




Figure 2 shows weight distribution of patients. The body weight of female patients was 
smaller. Mean body weight of female patients was 56 Kg, while that of male patients 
was 65. 
Body weight 
175�Fema le Male N=796 
150 - mean=56.09 mean=65.11 Mean=61.16 
> 125 - / y \ S.D.=11.30 
^ / / \ \ Max =109.2 
I T - / / \ \ 丨 … I 
25 _ D I - - M a l e 
0 ^ ‘ ‘ ‘ “ 1—5==±=Ht=r==i_I n=447 
35 45 55 65 75 85 95 105 ^ 
-•-Female 
Weight (Kg) n= 349 
Figure 2 Body weight of patients 
、 
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Three dose concentrations were randomly assigned to these patients. The exact 
amount of contrast media was calculated by multiplying the dose level by patient's 
body weight and rounded to the nearest milliliter. The amount of contrast media 
received by the patients is shown in Figure 3. The mean amount for female patients 
was 68.67 ml and the mean for male patients was 79.9 ml. 
Amount of contrast media administered to patients 
9 0 � , , 
|N=796 
Dfle . o o Mean=74.98 
& 6 � _ / / \ \ Max =146 
S J / \ \ Min=33 
L - / W 二 
/ / Female V \ + M a l e 
/ / Mean=68.7 V n=477 
0 L S I j . . , . , _ • • Female 
n=349 
35 45 55 65 75 85 95 105 115 125 135 145 — 
Amount (ml) 
Figure 3 Amount of contrast media given to patients 
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6.1 Overall frequency of reactions 
Overall frequency of reactions N=796 
4 0 % 「 
34% 
、、VK 丨 30% 
30% - 爾4;、： 卜 … … J 
22% 
^ 、-1: P. r f V ^ • � � � 
•I、,、、丨 「 〜 司 ：、“ i:、）、丨 《 、 
10% -糊 讀 ：趟 ：:、4， 
、、、、、、、〜、、-、、、•、-r- 。• ； 二、〈、“ � > � - -
； i i 
0% n,,,1 1 b — — I 1 、:、、、. • 
Immediate Delayed Both No reactions 
reactions only reactions only immediate & 
delayed 
Figure 4 Overall frequency of reactions 
Type of reactions ~Number of patients~ % 
Immediate reactions only 274 34 
Delayed reactions only 1 1 0 14 
Both immediate & delayed m ^ 
No reactions 2M 30 
Total m 
Table 7 Overall frequency of reactions 
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6.2 Gender difference of reactions 
Gender difference of reactions N=796 
p=0.613 p=0.000 
6 0 % � 540/0 56% 
X.v.v.v.v.w.v.v.v.y 
• I, I^'UliULV N 、。、、 ；、々  \ , : 、•"、、、、、 
； 9 , m � V k 430/0 
> 40% -：备赞？ 謹 Male 
I 300/ _ n=447 
] 、：i ： ： ：  y、'、 . . : .i-v 
o" 喊、、、込、：^  ‘、.、： ；、、、:v、r>"5\31公;、专、、\ 
I ；辩：、細、.： 、力] 面Fe， 
2 0 % - — H 减 : 忿 i ; l 、 C : : : 、 ' n=349 
0% L A I riT h、iVT. 1、vifc, I, m. •• _.,._丫’wi I t >. 、• •、 I. •...……,...’,• I 
Immediate reactions Delayed reactions 
Figure 5 Gender difference of reactions 
Reactions Male n=447 ~Female n=349~ Statistics(X2 test) 
No. of % No. of % Value d f p - v a l u e 
patients patients 
Immediate 243 ~ M 1% ^ O ^ i 0.613 
reactions 
Delayed 135 30 149 43 1 3 ^ 1 0.000 
reactions 
Table 8 Gender difference of reactions 
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6.3 All reactions vs. dose level for difTerent genders 
All reactions meant they were not differentiated into immediate or delayed reactions. 
Between 293 and 455 mgl/Kg of body weight, dose of contrast media had no effect 
on frequency of reactions in male patients. For female patients, there was an increase 




All reactions vs dose N=796 
HDose 1 
1 0 0 % � • Dose 2 
mDose 3 
p=0.893 p=0.075  
80% - 腦 
73% 
69% 69% ^70/ — 
67% 66% 6， 
, e o . - P F ^ _ 
吕 ：戈广 _ _ 
I t m s � � j _ 
芒概 -輸 s ^ v 醒 . . . 
念 於 ： ： 仗 、 。 、 “乂作’ 
觀 麵 _ .. 
20% -麵ffi ；‘；农：）• 
i i 勢 _ 
•o/o h：、、、八] 1\、、、.、”、1 • L ^ 2i , 
Male n=447 Female n=349 
Figure 6 All reactions vs dose level for each gender 
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i 
~ D o s e l Dose 2 Dose 3 I S t a t i s t i c s (X' test) 
No. of I % No. of I % No. of I % V a l u e df |p-value 
patients patients patients 
Male ^ ^ ^ m ^ ^ 2 0 ： ^ 
n=447 
Female ^ ^ 89 T% 5AS 2 OmT 
n=349 
Table 9 All reactions vs dose for each gender 
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6.4 All reactions versus dose level - genders compared 
Gender difference of reactions vs dose 
P=0.595 P=0.392 P=0.021 
0 80% 78% 
1 f l l N=796 
t 73% �� 
r-rrn � H Male 
70O/O . 69% 69% n=447 
K l f iRo / 、':、、： 6 7 % � �i i i Female 
� �: 1 : : � � n=349 
。、：：洛、• 餐 ： ^ 
/ 於、#�V、： ：、:、:、:、'、， ：；。、：、 
6 0 % / "……••~ I ~ L•丄』二 J _ I _ L _ L _ J _ I 
Dose 1 n= 264 Dose 2 n=264 Dose 3 n=268 
Figure 7 All reactions versus dose level - genders compared 
Figure 7 used data in Table 9 (P.36)，but re-plotted according to dose range. This shows 
more clearly that at higher dose level females had significantly more reactions than 
males. At lower dose levels no gender differences were shown. 
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6.5 Patterns of reactions 
6.5.1 Most common immediate reactions vs. gender 
Immediate reactions vs. gender  
Vomit f ^ P=0.128 _ a l e 
- � n , n=447 
Sneeze p=0.886 
- d Female 
Itching P=0.824 n=349 
Rash N=796 
Strange taste ^ ^ ^ P=0.991 
Nausea P=0.158 
- p=0.655 
Heat 1 ’ IT m 
—« I I 
0% 20% 40% 60% 
Frequency 
Figure 8 Most common immediate reactions vs. gender 
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Symptoms Male n=447 Female n=349 Statistics (X2 test) 
No. of % No. of % S m ^ d f p-value 
patients patients 
^ ^ 49 iTs 50 ^ i 
Nausea ^ 6 14 4 i ^ J ^ 
Strange taste in 18 4 14 4 ^ ； 
the mouth 
^ 9 2 14 4 ^ i ^ ^ 
Itching 8 2 7 2 ^ j Q ^ 
^ ^ 2 6 2 ^ i ^ ^ 
^ ^ 2 r " ‘ ^ ^ i S T ^ 
Table 10 Most common immediate reactions vs. gender 
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6.5.2 Most common delayed reactions vs. gender 
Delayed reactions vs. gender  
Dizzy ； 缴 P = 0 . 0 0 8 ilMale 
_ �� ° n=447 
Joint pain , … 關 Female 
: � . � � . . �. 0 n=349 
Gl upset 广、二：严 ~ n i 2 % P=0.006  
- N:796 
: . . . . . . . . . . . … 
Itching \ ” j �？ 、 > � 3.00/ 
^ 、、、-、.:-.、-、 ‘ 113。/o p=0 .009 
Rash • 
代日sn : A � \ : � � x —入 、 . � :� .• 114% p=0.000 
Fatigue •… ”•••:•…'^ »^^  • ^；^»• •^ “• • > . • • • • - • • ^  117% �p = 0 _ 0 3 0 
^ 广 、…… ……^— 」 、 ->-——、-- I ^o /o 
L 1 1 I 
0% 10% 20% 30% 
Frequency 
Figure 9 Most common delayed reactions vs. gender (Part 1) 
Delayed reactions vs. gender  
Arm pain P=0.007 _ a l e 
- n=447 
S.o.B. 1 ^ 5 0 / 0 P二0.007 面 Female 
“^^^^^  n=349 
Difficult urination p:o.008 
: N=796 
Heat 5 i z Z 3 6 % P = 0 - 0 0 1 
Salivary gland ： : … ？ , 丨 6%P=0.000 
Headache、，::,，'"外…,"p=0.004 
丨 ‘ 
0% 10% 20% 30% 
Frequency 
Figure 10 Most common delayed reactions vs. gender (Part 2) 
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Symptoms Male n = 4 4 7 F e m a l e n=349 Statistics (X2 test) 
No. of % No. of % Value df p-value 
patients patients 
Fatigue T5 17 80 ' ] ^ 4?71 1 oiosT 
Rash 27 5 49 14 1 OJOoF 
Itching ^ 7 45 13 ^ 1 oiSST 
Gastrointestinal 28 6 41 12 \ 0 0O6 
upset 
Joint pain 13 3 40 12 2 3 ^ 1 0；000~ 
^ ^ 5 n 9 i m i oiooT 
Headache 17 4 ^ 9 ^ i 
Salivary gland 1 0 ^ 6 2313 i O^OOO" 
swollen/pain | 
Heat 4 1 19 6 1 o m T 
Difficulty in 8 2 Fs 5 ^ j 
urination 
Shortness of 7 2 17 5 7^2 1 omT 
breath 
Arm pain 7 2 17 5 732 1 O m T 




6.5.3 Onset time of delayed reactions 
No. of Minimum Maximum Mean Standard 
patients (hours) (hours) (hours) deviation 
1 
Time of onset 269 U 130.08 16.94 2 ! ^ 
(post-injection) (5.4 days) 
Table 12 Onset of delayed reactions in hours postH'njection 
These were rough estimates since most patients could not report the exact onset time 
of delayed reactions. Some data were not available because time of injection was not 
recorded. Total number of delayed reactions was 284, while time of onset was only 
available in 269 patients. Also any onset after phone interview was not available. 
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O ;、 \、， 
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、、： 1 4 % n = 1 0 n = 6 
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Days post-injection 
Figure 11 Onset of delayed reactions in days post-injection 
Onset of delayed reactions Frequency % Cumulative % 
Less than 1 day (24 hours) 214 79.6 
1 to 2 days ^ IAS m 
2 to 3 days 10 3 J 97^ 
3 to 4 days 1 M ^ 
4 to 5 days 3 U ^ 
More than 5 days 2 0.7 
Total 100 
Table 13 Onset time of delayed reactions in days 
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Onset of delayed reactions ranged from 66 minutes to five and a half days in this 
series. The mean onset time was 17 hours post-injection. Majority of reactions 
(79.6%, n=214) occurred within one day post-injection. Another 14.5% (n=39) 
occurred within the next 24 hours. Therefore, 94.1% of delayed reactions occurred 
within 48 hours after injection. 
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6.6 Reactions to different contrast media 




6 0 % -
p=0.006 N=796 
0 43% 
S 40% • Nonionic 
1 40% - ^ ^ ^ s T ^ B f — 1 31% n=442 
20% - n=354 
0 % ^ ‘ ^ ‘ 
Immediate reactions Delayed reactions 
Figure 12 Frequency of immediate and delayed reactions vs. contrast media 
Nonionic lopamiro Ionic Urovison Statistics (X^ test) 
No. of % No. of % Value ^ p - v a l u e 
patients patients 
Immediate m S ? 12^ 68.98 1 0.000 
reactions 
Delayed m 4^42 1 0.006 
reactions 
Table 14 Reactions to different contrast media 
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6.6.1 Reactions to different contrast media vs. gender 
Immediate reactions to different contrast media 
vs gender 
。。。， p=0.016 P=0.393 
跳 r 72% 
60% - 键〜^^‘ 
4 9 % 炉、％、^、：二、. •、⑶> 
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Nonionic lopamiro Ionic Urovison 
Figure 13 Immediate reactions to different contrast media vs. gender 
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Delayed reactions to different contrast media vs gender 
p=0_013 p=0.020 
5 0 % � 460/0 
：、；、、：^、、^ 
40% - ;>r"<、： 37% 
34% 
:、、；<、〜—（、“）、。 ：、�v:�、：：、广 11 Male 
10% - 二 攻 、 
j ^ ： f�，丨 N � ) 冬 、 :n = 3 4 9 
K:v、。、、、、t ...... I "m_、;,••?.!•"•• �•••••�•�•••_"�� J 1  
Noninic lopamiro Ionic Urovison 
Figure 14 Delayed reactions to different contrast media vs. gender 
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Male n = 4 4 7 F e m a l e n=349 Statistics (X^ test) 
S ^ _ 
•B I ••5 No. of % No. of % Value S f p - v a l u e 
w s ^ 
s o s 
fi ^ patients patients 
^ ^ 49 ^ i 0.016 
s f 
1 s I 
1 ^ ^ ^ ^ i 0.393 
S e 
HH o ^ ^ 




^ 34 ^ ^ ^ i 0.013 
2 I 
I s I 
•o ^ sS 
I ^ ^ ^ ^ i 0.020 
Q c 
I g f 
o ^ o 
p ^ 
Table 15 Reactions to different contrast media vs. gender 
V 
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6.6.2 Patterns of reactions to difference contrast media 
Most common immediate reactions vs. contrast media 
Immediate reactions to different contrast media  
Vomit [^ �含。/o p=0.000 • Nonionic 
- n=442 
Sneeze U^^/o P=0_018 
. • Ionic 
Itching ^ V / o •的5 帕 5 4 
Rash • V / � P = 0 . 0 0 4 N=796 
Strange taste 遍 。 P = 0 _ 0 1 4 
Nausea ^ ^ m�卩=0_000 
Heat S i i i i ^ ^ ^ ^ m ^ e 590/0 
1 1 1 ! I 
0% 20% 40% 60% 80% 
Frequency 
Figure 15 Most common immediate reactions vs. contrast media 
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Symptoms Nonionic Ionic Urovison Statistics (X^ test) 
lopamiro n=442 n=354 
No. of % No. of % Value S p - v a l u e 
patients patients 
Heat 4r2 ^ ^ 25^ 1 0.000 
Nausea 5 U 37 S I 1 0.000 
Strange taste in 11 ^ 2 \ 5.9 ^ 1 0.014 
the mouth 
Rash 6 \A 17 4^8 ^ 1 0；004~ 
Itching 3 OJ 12 ^ i J l i 0M5~ 
Sneeze 3 0.7 10 1 
Vomit i 02 12 3A 12.246 1 OOOO" 
Table 16 Most common immediate reactions vs. contrast media 
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Most common delayed reactions vs. contrast media 
Delayed reactions to different contrast media  
Dizzy p=0.540 
Joint pain ^ ^ 9% p=o,006 • ionic 
： n=354 
Gl upset p=o.090  
- N=796 
Itching — — 7 % ‘ p=0.020 
Rash 、12%p=o.OOO 
Fatigue 21 % p=o.285 
0% 10% 20% 30% 
Frequency 
Figure 16 Most common delayed reactions vs. contrast media (Part 1) 
Delaved reactions to different contrast media  
Arm pain p=0.580 • Nonionic 
^ ^ n=442 
S.O.B. p二0.125 Bionic 
： n=354 
1 
Difficult urination ~ ‘ p=0.008  
- _ N=796 
15% 
Heat • ” / o p=:0.001 
Salivary g l a n d � o /�丨 4 % psQ.OOl 
Headache m i ^ 認 p=0.740 
^ 1 I I 
0% � 10% 20% 30% 
Frequency 
Figure 17 Most common delayed reactions vs. contrast media (Part 2) 
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Symptoms Nonionic lopamiro “ Ion ic Urovison~ Statistics (X^ test) 
n=442 n=354 
No. of % No. of % Value df p-value 
patients patients 
Fatigue n ^ « 17^ L H 1 0 2 ^ 
M 112 17 4；8 l l 3 i oiooo" 
Itching 53 12 ^ ^ ^ 1 
Gastrointestinal 45 10.2 ~ ~ ^ M i 0.090 
upset 
Joint pain 39 O 14 4^0 T49 1 0^00^ 
Dizzy 31 To Yl 037 1 0540~ 
Headache 25 ~ 5 J 22 ^ ^ j 0.740 
Salivary gland 19 43 2 06 10.668 1 oiooT 
swollen/pain 
Heat 4；8 2 06 1 O l O o T 
Difficulty in 21 48 5 \A ^ 1 ao08~ 
urination 
Shortness of 17 ^ 7 ^ ^ j o.l25 
breath 
Arm pain ~~12 ^ 12 ^ o3o 1 0 5 ^ 
Table 17 Most common delayed reactions vs. contrast media 
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6.7 Management of reactions 
Although many patients (448 patients, 56.3% of total) suffered from immediate 
reactions, the majority responded to nursing care and assurance. Only two patients 
had Chlorpheniramine injection, while one had oxygen. In other words, only 0.7% of 
the 448 patients who had immediate reactions needed medical treatment due to the 
reactions. 
There was another patient who suffered hypotension and was admitted. This case 
was excluded since the 12-minute film was not taken. He was discharge without 
further problems the next day. 
On the other hand, a total of 284 patients (35.7% of total) suffered from delayed 
reactions. Of these 20 patients (7% of 284) sought medical attention. Another 23 
patients (8.1% of 284), who although they suffered from similar unpleasant 
symptoms, did not consult a doctor. 
Seventeen patients received treatment caused by delayed reactions and 33 patients 
who did not seek medical attention had self-prescribed treatment, e.g. analgesia, 
ointment, etc. That gave a total of 50 patients (17.6 % of 284) who required 
treatments due to delayed reactions. 
From the above figures, it could be postulated that delayed reactions were more 
unpleasant than immediate reactions, just as Davies (1998) wrote, 'delayed reactions 
to urographic contrast medium are more common than acute reactions, often more 
unpleasant and some have been fatal. There are reports of effects on most organ 
systems.' (8, 39) 
The notion that delayed contrast reactions were more common than acute 
(immediate) reactions might be because immediate heat sensation was not counted as 
a reaction. If so, it agreed with the results in the current study. If heat was not 
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counted, only 115 patients (14.4% of 796) had immediate reactions, less than the 
35.70/0 (284 patients) who had delayed reactions. (Please see Section 7.3.1 Heat 
i 
sensation, P.73) ‘ • 、 
• { .. • 





6.8 Summary of reactions 
In summary, all the reactions recorded in this study, both immediate and delayed, 
were minor reactions. Each reaction are listed below, with an attempt to discuss their 
mechanisms, gender difference and contraj>l difference. Kruskal-Wallis Test 
showed that dose of contrast media had no effect on the prevalence of all the 
reactions investigated. But It appeared that all the small, insignificant differences 
added together led to increased frequency of overall (immediate and delayed) 
reactions in respond to increasing dose in female patients. 
Mechanism ~Gender~I contrast type 
(*=likely to be modified by difference difference 
corticosteroids) 
Immediate reactions Male (M) vs. Nonionic (N) 
Female (F) vs. Ionic (I) 
Rash* Urticarial skin reactions are None 
Itching* anaphylactoid reactions. No treatment is None 
required for most patients (14). 
Sneeze or Reflex caused by action of contrast None 
yawning media on the central nervous system (7) 
Vomit Direct contact of contrast with postrema, None 
Nausea the known defect in the blood-brain None 
barrier, and site of the trigger zone for the 
nausea and vomiting center (37). 
、 
Heat Chemotoxic reactions. May be due to None 
Strange taste osomolality of contrast media (40) None I>N 
in the mouth 
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Mechanism ~Gender~I contrast type 
difference difference 
Delayed reactions with known possible mechanism Male (M) vs. Nonionic (N) 
Female (F) vs. Ionic (I) 
Rash Allergy-like reactions* (41). F>M 
Itching F ^ NM 
Heat F ^ N ^ 
Shortness of F>M None 
breath 
Gastrointesti 'lodism', which is associated with raised F>M None 
nal upset plasma inorganic iodide (8’ 42) 
Headache F>M None 
Salivary The salivary glands actively concentrate F>M N M 
gland large amount of iodide. Iodide 'mumps' 
swollen/pain is more common in patients Wul, \ dial 
insufficiency (42), causing ductal cell 
swelling and obstruction of the ducts 
with inflammatory swelling (19). This is 
an idiosyncratic reaction (42). 
Arm pain May be due to toxic effect on the F>M None 
endothelium with thrombophlebitis. Due 
to osmolality and sodium concentration 
of the contrast medium (43). 
t 
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Mechanism Gender contrast type 
difference difference 
Delayed reactions with unknown mechanism Male (M) vs. Nonionic (N) 
Female (F) vs. Ionic (I) 
Fatigue The exact pathogenesis of delayed F>M None 
Joint pain reactions is still unclear. There is F>M n M 
Dizzy increasing evidence that a signiiicant F>M Same 
Difficulty in proportion of the reactions is T-cell F>M 
urination mediated (18). 
Table 18 Summary of reactions recorded in this study 
While there are lots of papers and textbooks explaining mechanisms of severe 
contrast reactions, there are very few data concerning minor reactions. Minor 
reactions are the most frequently encountered reactions and have the most effects on 
patients. More researches need to be performed on minor reactions and their effects 
on our population. Note that many of these reactions would not be considered to be 








3. The types of contrast agent 
4. Three levels of dosage 
5. Steroid cover 
6. Two categories of reactions - immediate and delayed. 
It has been established that studies on contrast media reactions are difficult to 
execute (44, 7, 45) and this study is no exception. In this research study, several 
difficulties were encountered. 
1. There were more male than female patients who came for intravenous 
urography, the numbers were 447 and 349 respectively. Although patients of 
each gender were treated independently to maintain similar number of patients 
receiving each dose of contrast media, the difference in total number added to 
the complexity during analysis. For male patients, 146 patients had dose 1, 145 
had dose 2, and 156 had dose 3; while the respectively numbers for females were 
118, 119 and 112. In order to recruit an adequate number of female patients, 
even more male patients were included. 
2. The choice of contrast media could not be randomized. This was due to ethical 
reasons. We could not assign a high osmolar, ionic contrast medium to high-risk 
patients. However, this was in line with the daily routine in our department. 
Therefore, the results actually reflected the real-life situation in our department. 
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3. There was no placebo population. For this kind of exam it is impossible to 
administer placebo. 
4. It was difficult to distinguish between genuine and false delayed reactions (46). 
Fortunately, the patterns of delayed reactions had been quite consistent in the 
results. Various precautions had been taken to prevent Type I and Type II errors. 
> A list of common delayed reactions had been compiled according to the 
literature (33) and incorporated into a questionnaire. 
> Every patient, on leaving the department after the IVU exam, was given an 
'Aftercare leaflet' stating possible delayed reactions they may encounter in 
the following two days, and that thev would be called two days later. This 
was for patients' information. A copy of the questionnaire was also 
attached. Some patients actually had the questionnaire filled out and 
reported to the interviewer. Others recalled their experience during the 
phone interview. 
> This was a double-blind study. Patients had no idea of the kind or dose of 
contrast media given to them, so apparently every patient was treated the 
same. Should they be 'primed' or directed to any answers, the answers 
should be uniform rather than showing different patterns to different 
contrast medium, dosage, and gender. This situation (patients had the same 
response) did not happen (please see results). 
> At the beginning of phone interview, patients were asked to report any 
delayed reactions. The open question yielded most of the results as patients 
usually managed to give comprehensive accounts of their symptoms. 
> Then questions on each reaction on the list were read, for the patient to 
comment if he/she had any of the symptoms. 
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> Some researchers excluded the same symptoms that occurred within 12 
months prior to contrast media injectlo.. (47). However, other researchers 
have suggested that some pre-existing disease, e.g. heart failure and renal 
failure, were aggravated by contrast media injections (8). 
The current study included symptoms that the patients never experienced 
before injection, as well as those they may have had before, but had already 
subsided long before injection (maybe less than 12 months). In many cases, 
patients could tell whether the symptoms had recurred after the injection, or 
were totally unrelated to the injection, and coincidental. Patients were not so 
sure for symptoms they encountered for the first time whether these were 
due to the injection or not. 
I 
> Fatigue was the most common delayed reaction. Patients typically felt very 
sleepy, particularly their eyes felt very tired. Many of them slept after a few 
hours post-exam. Some patients had to retire from their routines for a few 
days; e.g. some had to omit their daily morning exercise. Some patients felt 
exhausted after injection. This particular reaction emerged during the study 
as being of clinical significance. Unfortunately the importance of this 
reaction had not been appreciated at the time of the design of the study so 
the level of detail obtained left several questions unanswered. 
> Patients who felt slightly tired, but whose daily life was not affected, were 
not counted as having a reaction. It was because some patients pointed out 
/ 
that they might feel tired after travelling to the hospital for the exam, and 
also they were not concerned as long as the tiredness was not so bad as to 
interfere with their routines. 
5. Many studies with large number of patients are multi-centered trials. It was 
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difficult to execute accurately if the experimental design was complex. 
The current study was conducted in two adjacent x-ray rooms, run by the same 
team of staff Immediate reactions were observed by any of the 16 nurses in the 
department, and delayed reactions were reported to a single observer. Therefore, 
the study was conducted under tightly controlled and monitored conditions. The 
disadvantage was that relatively small number of patients (in comparison to the 
large multicentre trails) had been recorded during a long period of time. 
6. Some patients were difficult to contact. Some returned to Mainland China after 
the exam. Most patients were only available during the evening. Each patient not 
contacted was called at least once more a few days later. Fortunately, many 
patients were contacted by calling their mobile phones. Some patients reported 
by phone before they were contacted. 
Some researchers employed mailed questionnaires. The response rate was about 
84%, which was very high (48). However, this might not be the method of choice for 
busy people in Hong Kong. Furthermore, it was not easy to establish who answered 
the written questionnaires, and there is always the possibility of response bias, which 
results were based on a sample of respondent who were highly motivated to answer 
the survey's questions (49). 
t 
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7.0.1 Why delayed reactions not available 
Reason Frequency Percentage 
Patient unavailable for ^ 21.8% 
phone interview 
Wrong phone number 24 2.2% 
Language barrier 13 1.2% 
Patient forgot about exam 3 0.3% 
None (interviewed 796 74.5% 
successfully) 
Total 100% 
Table 19 Reasons why delayed reactions were not available 
N 
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7.0.2 Profile of immediate reactions for patients not available for 
phone interview 
The presence or absence of delayed reactions of patients who were not available for 
phone interview could not be analyzed. However, the profile of immediate reactions 
could be used as a checking mechanism. If the profile was the same as the other 
patients in the study in whom delayed reactions would be studied it would suggest 
that the non-responders would be likely to be similar. This would support the ‘ 
assumption that the non-responders had reacted in a like manner and did not respond 
because they were suffering even more severe delayed reactions, and it was proved to 
be the same as the rest of patients. 
Total 274 patients Frequency % 
Gender Male 175 S I 
Female ^ 35^ 
Steroid covered for this exam? Yes 58 21.2 
n5 216 TO 
Contrast medium Nonionic lopamiro 159 58.2 
Ionic Urovison 115 41.8 
Immediate reaction No 134 48.7 
^ 140 5 U 
Table 20 Profile of patients only immediate reactions were available 
There were significantly more female patients (p=0.000) who were steroid covered, 
and more females had nonionic contrast medium (p=0.043) than males. There was no 
significant gender difference in the frequency of immediate reactions (p=0.283). 
There was no significant gender difference in the frequency for individual symptoms 
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for all symptoms of immediate reactions. All these findings agreed with the rest of 







7.1 Reliability of patients' response 
738 (92.7%) of the 796 patients himself/herself answered the phone interview. There 
were only nine patients who claimed they had immediate contrast media reactions, 
which was not recorded by the nurses. Therefore, the results for delayed reactions 
should be highly reliable due to the small discrepancy between the two categories of 
reporters (nurses and patients). 
7.1.1 Informant 
Informant Frequency Percent 
Patient's grand daughter 1 0.1 
Patient's sister 1 0.1 
Patient's son-in-law 1 0.1 
Staff in home for aged 2 0.3 
Patient's daughter -in-law 3 0.4 
Patient's husband 3 0.4 
Patient's son 9 U 
Patient's daughter 14 iTs 
Patient's wife 24 
Sdf ^ ^ 
^ 100 
Table 21 Distribution of informant who answered phone interview for delayed reactions 
Some patients did not answer personally because of language barrier, or bad hearing 
sense. Their relatives, or staff from the homes for aged, answered the questionnaire 
• after gathering information from the patients. 
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7.2 Results of quality control (by comparators) 
7.2.1 Relationship between image quality and contrast media 
dose 
A total of762 12-minute IVU films were evaluated. 96% scored 2 marks or above, that 
is, of diagnostic opacification quality. 
Image score Vs Dose N=762 
50�/� Spearman's correlation 
coefficient = 0.109 
p=0.003 
40% - ~~hi 
��� 
O 30% - � ' , m 
§ 、 「 丨 / 
o-
22 2 0 % - 门 ： ？ 
Li. :； 丨、 
； > 「 
r n iv “ , 
0% F ^ f - ^ I I I I 1 I I I }、1 I I I f I I I I I I 
0 1 2 3 4 5 
• Dose 1 1% 4% 20% 42% 26% 8% 
• Dose 2 2% m 12% 41% 33% 11% 
In Dose 31 2% 2% 13% 40% 33% 11% 
Score 
Figure 18 Relationship between image quality and contrast media dose 
From the above figure, the majority of films scored between 2 and 4 marks. There was 
significant correlation between image score and dose, that is, a film was expected to 
score higher when the patient received a larger dose of contrast media proportional to 
the patient's body weight (p=0.003). 
However, the correlation coefficient was only 0.109. Therefore, clinically the 
relationship between image quality and contrast media dose in the range used was 
weak. 
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Increasing dose to a patient might not yield a better film, or the effect would be 
small. However, for female patients, whose tolerance to contrast media dose was 
lower, increasing the dose beyond 300 mgl per Kg of body weight would expose the 
patient to a higher risk of contrast media reactions. 
、 
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7.2.2 Opacification quality by different contrast media 
Quality score vs contrast media 
N=762 
590/0� Kruskal-Wallis Test 
45% p=0.889 
40% - 38。>^ | • Nonionic 
| — l o p a m i r o 
• 30。/31% n=428 
H 30% - • •ionic 
§ • • Urovison 
cr • • n=334 
I 20% - I I  
M • • 
10% - • • • r i ^ 
0% r ^ I l I r \ m I l _ i l - j l _ i l _ j 
0 1 2 3 4 5 
Score 
Figure 19 Opacification quality vs different kinds of contrast media 
The Kruskal-Wallis Test compared the quality score between the two types of contrast 
media. There was no difference between quality and the type of contrast media used, 
for the dose of 300 - 450 mg I/Kg of contrast media given to patients. 
Therefore, patient safety and cost of contrast media such be considered when deciding 
which contrast medium to use. 
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7.2.3 Opacification quality vs. gender 
Quality score vs. gender 
N=762 
2 0 0 � 188 X^test 
n i l P=0.060 
vA ； I 
(� 11 Male 
150 - 巧 n=424 
> V:I22 122 
0 、 、 ； E T ^ I O „ _ • 
g V • Female 
1 100 - 、 ， � …n = 3 3 8 
2 々 : / :《：、- 
LJ- 63 、：。” ：、’：、丨 
、、、 、 ！ 
50 - 、： ^ ；：‘ ：、:卜: 36 40 、、i � 、、.:.、 • - • • '•� ITWSl 
i 、、、j i ;、.：’、 : 
2 o ^^ ^^  7 :、 � ��V ^ r/ .� \ � i � 、 
0 — s • . 1 1 A • I - 1 1 . 1 j i • [ 1 I . 
0 1 2 3 4 5 
Score 
Figure 20 Opacification quality vs. gender 
The gender difference of image quality was marginally significant (p=0.060). The 
impression was that while females had the majority of images achieving higher scores, 
most films of male patients concentrated into the middle grades, that is, of average 
quality. The p-value of Mann-Whitney Test was 0.429, meaning that there was no 
gender difference in the mean scores. 
Within female patients alone, the p-value of Kruskal-Wallis Test was 0.082，meaning 
there was no difference in the mean scores as an effect of dose. That meant that image 
quality could not be improved significantly in female patients, but there was 
increasing risk of contrast reactions with increasing dose to females. 
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7.3 Overall frequency of reactions (both contrast media，immediate and 
delayed reactions) 
Type of reactions Number of patients Percentage (%) 
Immediate reactions only ^ ^ 
Delayed reactions only nO \4 
Both immediate & delayed \74 ^ 
No reactions 238 39 
Table 22 Overall frequency of reactions 
Table 22 is a replica of Table 7 (P.32). 
Referring to Table 22, a total of 70% of patients suffered from some kind of reactions 
after intravenous urography. Some patients suffered from more than one symptom. 
、 
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For immediate reactions, 324 patients suffered only heat and no other symptoms. 
Excluding immediate heat, the chart appeared as below. 
Number of immediate and delayed reactions experienced by 
20% r patients ^otal N=796 
0 Sensation of 
© heat excluded 
tCOA _ 2 15% 
iDZo t _ H Number Of 
immediate 
m reactions 
- - 1 n 口 s r 
1 . ^ ^ 
5% - _ 4% 门 
� % i . I . : . o % n . 0 % ! ^ . . 
1 2 3 4 5 6 
Number of reactions to both contrast media 
Figure 22 Number of reactions experienced by patients, when 'sensation of heat' was excluded 
More patients suffered delayed reactions than immediate reactions, if heat was not 
counted as a reaction, and more patients suffered more multiple reactions in the 
delayed period than in the immediate period. 
Therefore，there should be a greater awareness of these facts and patients must be 
warned of possible delayed reactions since the frequency was as high as 36%. 
、 
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7.3.1 Heat sensation 
If heat sensation was excluded as an immediate reaction, there was slight change in 
the pattern. The difference occurred with reactions to different contrast media vs. 
gender. According to Table 15 (P.48), there was significant gender difference within 
immediate reactions with nonionic lopamiro. However, there was no significant 
difference when heat sensation was excluded. 
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Immediate reactions, excluding heat sensation 
30%「 P=。.255 P = 0 】 
240/0 25% 
P.!•�: 
翁 ! ： 象 ： N=796 
§• 12 2T4 舰 : 、 k、： • 二 7 
•S 990 � > � � � \ � � \ n=447 
^ 10% - 228 8 % 、飞:“；丨、:\、广《 
5% p r — i U Female 
I — 二 "心V 丨� : � �： n=349 
、i、v\ •、、、、《 \、>、�、4、、 
、‘V"、:、、、 , i ； 
QO/o ^^、一如”二,.！ . , 
Nonionic lopamiro Ionic Urovison 
Figure 23 Immediate reactions to different contrast media vs. gender, excluding heat sensation 
There were some changes in the pattern comparing with Figure 13 (P.45). 
Male n = 4 4 7 F e m a l e n=349 Statistics (X^ test) 
S ts 典 I  
•S s '-B No. of % No. of % Value S p - v a l u e 
a c « ^ 
§ e g 
^ ^ patients patients (X^ test) 
一 o 12 53 17 r9 \29 i 0.255 
o 2 
. i I 
I ^  
I ^ ^ S 312 ^ i 0.759 
S to 





Table 23 Immediate reactions to different contrast media vs. gender, excluding heat sensation 
、 
The reason for this change in observations was that more female patients suffered from 
immediate heat sensation after injection of nonionic lopamiro. 
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Heat sensation only 
N=442 
5 0 % � p=0.059 
41% 
40% - � “S - J 
33% 
^ IL、（.、14 .IH. 〉/、、：’、 
I 30% _ |�t：技丨 |_Malen=228 
营 2 0 % - : : : 均 . 「 ； h Female n=2141 
、：、八 -、、：站 
10% - 、：： y 、…'“： 
》，〉:：： ；、：、、r 
0 % — I — I I 
Male n=228 Female n=214 
Figure 24 Patients suffered from heat sensation only after injection of nonionic lopamiro 
g u Male n=228 Female n=214 Statistics (X ' test) 
J <» 
1 1 1 No. of % No. of % Value d f ~ p-value 
^ c I 
2 2 patients patients 
W o 
" T ” ” : ^ ^ ^ 4 U i 0.059 
2 .a 
•_ cs 
S § l 
§ 
- s 
Table 24 Patients experienced from heat sensation only after injection of nonionic lopamiro 
、 
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Though insignificant, more female patients experienced reactions after nonionic 
lopamiro. The cumulative effect of all reactions including the heat sens3>tion resulted 
in significantly more female patients experiencing more immediate reactions after 
injection of nonionic lopamiro. 
Contrast Male n = 4 4 7 F e m a l e n=349 Statistics (X^ test) 
media No. of % No. of % Value ^ p - v a l u e 
patients patients 
lopamiro 300 86 38 49 j 0 . O I 6 
(nonionic) 
Urovison 157 n ^ ^ ^ i 0.393 
58% (ionic) 
I ‘ 
Table 25 Immediate reactions to different contrast media vs. gender 
Table 18 is part of Table 15 (P.48). 
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7.3.2 Delayed iodide mumps 
Iodine induced mumps has been described in almost all textbooks of delayed contrast 
media reactions. The symptoms of iodide mumps were pain and/or swelling of 
salivary glands. The occurrence was 1%, accoHi"^ to Davis (8). 
However, in this series, there was only 1 male patient who had experienced this 
symptom, in contrary to 20 female patients (6% within the females). The average 
frequency was 2.6% among the total of 796 patients. 
Patients who suffered from pain and/or swelling of the salivary glands could not have 
mistaken or missed the symptom. Most patients had parotid glands involved, more 
bilaterally than unilaterally. A few had described pain underneath the mandible, 
where the submandibular glands situated. All claimed they had never had such 
symptoms before. 
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7.4 Patients' age 
According to Bush (1998)，reactions occurred most frequently in patients 20 to 50 
years of age, but were more severe in older persons (4). In the current study, the 
mean age of patients who had immediate reactions was 52.8 years, but the mean age 
of the patients without any immediate reactions was 58.4 years, and the age 
difference was significant for reactors and nonreactors of immediate reactions. 
On the other hand, there was no significant difference in mean age between patients 





Mean = 55.2 
S.D. = 15.51 
2QQ Mode = 45，63 
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Figure 25 Age distribution of all patients in this study 
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7.4.1 Patient age and prevalence of reactions 
Independent samples test showed that mean age was different with reactors and 
nonreactors of immediate reactions but not delayed reactions. 
No. of ^ ^ A g e (Years)~~~ Statistics (t-test) 
patients Mean t d f p - v a l u e 
Immediate No 34S 5.132 ^ o.OOO 
reactions Yes 448 ^ v ^ 
Delayed No SU ]J69 0.071 
reactions Yes ^ 53^ ~ 
Table 26 Mean age of patients with and without reactions 
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There was a significant difference between the mean age of those patients who had 
immediate reactions and those patients without immediate reactions. The age 
distribution of patients who had immediate reactions agreed with Bush, that is, the 
highest frequency occurred in the 20 to 50 age groups (4). 
Age distribution of patients who had immediate reactions 
100O/0 r 『 8 
Mean = 52.8 
Mode=45 
80% • S.D. = 14.55 
I / \ 
li： 40% -
20% - \  
\ . 
0% • 1 1 1 1 1 1 i—^__I 
15 25 35 45 55 65 75 85 95 
Age (Years) 
Figure 26 Chart showing age distribution of patients who had immediate reactions 
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Age distribution of patients who had delayed reactions 
1000/O� N=284 
Mean = 53.9 
Mode = 45 





0% ‘ “ 1 1 1 1 1 1 
15 25 35 45 55 65 75 85 
Age (Years) 
Figure 27 Chart showing age distribution of patients who had delayed reactions 
Note: 100% of patients in the group 91-100 had delayed reactions because there was only one 
patient in the group 
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7.5 Why were there more delayed reactions after injecting nonionic lopamiro? 
Almen's paper in 1969 brought about the major development of contrast agents, the 
nonionic contrast media (1). Dawson (1988) summarized the advantages of nonionic 
contrast media: ‘The nonionic agents are highly hydrophilic agents of low protein 
binding capacity and possess very low chemotoxicity.，(16). Lasser (1992) also gave 
a detail account stating that nonionic contrast media should cause less reactions than 
ionic contrast media (37). 
However, it has been reported that nonionic agents caused more delayed rash and 
parotid swelling than ionic agents (50), and ihe current study has revealed more 
delayed reactions after injection of nonionic lopamiro than ionic Urovison (Figure 
12，P.45). This observation seemed difficult to explain. 
A closer look at the data revealed one important factor governing the choice of 
contrast media used, namely, whether the patient presented with high risk for contrast 
media reactions. In this study, 196 patients had been identified as high risk and were 
given steroid cover. All these patients had nonionic lopamiro, while the rest of 
patients not at risk had nonionic lopamiro or ionic Urovison. 
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7.5.1 Contrast media administered 
Steriod covered Contrast media 
for this exam? Nonionic lopamiro Ionic Urovison 
^ 176 
(100.0%) 
No ^ ^ 
(42.9%) (57.1%) 
Figure 28 Choice of contrast media vs. status of steroid cover 
High-risk patients, who were steroid coverp.H had significantly more delayed 
reactions than those who were not covered. These were true for both genders that 
received nonionic lopamiro. 
• 
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Delayed reactions vs steroid cover 
70�/� P=0.001 P=0.000 
° r 60% 
g 40% - ^ H 32。/。 I •Stero id 
I 30% _ 謹 27% ⑵vered 
“ 观 _ _ # 、 : ： 國 NO 
QO/^ - \ I ^ ^ ^ ^ …二•……hnl _ l — 
Male n=447 Female n=349 
Figure 29 Frequency of delayed reactions after injection of nonionic lopamiro 
Gender Contrast Steriod Delayed reactions Statistics (X^ test) 
media covered? No. % Value df p-value 
Ma le l o pam i ro 300 y S ^ 11.98 1 0.001 
No 43 27.0 
Female lopamiro 300 Y S M ^ 16.94 1 0.000 
No 34 31.8 




Delayed reactions to different contrast media in 
patients without steroid cover 
N=620 
4 0 % � P=0.674 
290/0 31% 





0% ‘ ^ H I H 1 
Nonionic lopamiro n=266 Ionic Urovison n=354 
Figure 30 Within patients without steroid, there was no difference in delayed reactions for both 
types of contrast media 
Delayed reactions Statistics (X^ test) 
No. of patients % Value p-value 
lopamiro 300 77 0.177 0.674 
Urovison 58% 108 
Table 28 Frequency of delayed reactions vs different contrast media, in patients without 
steroid cover 
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If patients who had steroid were excluded, there was no difference in the frequency 
of delayed reactions between the two kinds of contrast media. This may explain why 
previous studies have not observed that nonionic contrast media cause more delayed 
reactions than ionic contrast media, especially in a laboratory environment, where 
careful screening excluded high-risk patients. 
However, in the everyday clinical situation about one-quarter of patients will be in 
the high-risk group. These patients received nonionic contrast media, and they have 
significantly more delayed reactions. These gives the phenomenon that injection of 
nonionic contrast media results in more delayed reactions than ionic contrast media. 
In the 1998 collection of papers Davies commented 'The detailed study of delayed 
reactions started about the same time as the introduction of low osmolar contrast 
media. It should not, therefore, be supposed that the subsequent case reports of 
delayed reactions associated with the use of these media indicate that patients are 
more at risk from low osmolar media than when high osmolar media are given (or 
vice versa).' (8) 
The same author wrote in 1993 that for nonionic contrast media, '...some reactions 
are reduced, others have the same incidence for the two groups of contrast media and 
very large numbers in controlled trails are required to answer the more interesting 
questions.' (39) 
The above analysis and discussion showed that patients who were steroid covered 
(high-risk patients) had significantly more delayed reactions than those who were not 
covered. It appeared that the cause of frequent delayed reactions was actually within 
the patients themselves rather than due to nonionic contrast media, which agreed 
with Davies: '...the most important factors undoubtedly reside in the patient.' (8) 
Interestingly, Bettman et. al. (1997) after analyzing large amount of data from reports 
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to the Society of Cardiovascular and Interventional Radiology, concluded that '...it is 
clear that LOCAs (low osmolar contrast agents) offer statistically significant 
advantages in certain situations and little or no advantage in others. The degree to 
which this statistically significance is clinically relevant is difficult to 
determine...Other patients, such as those without risk factors and those undergoing 
arterial interventional procedures, are unlikely to benefit from the use of LOCAs.' 
(17). 
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7.5.2 Steroid cover and reactions 
Patients considered to be at high risk were steroid covered before attending the 
intravenous urography appointment. In this study, 196 patients had steroid cover. All 
these patients had the nonionic contrast medium, lopamiro. If these 196 patients were 
treated as a different group in calculations, a different picture for reactions was 
revealed. 
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Immediate reactions, gender and steroid cover 
p=0.325 
80% r 740/0 
p=0.002 p=0.317 1 6 3 ^ 
60% - 540. 
^ 鬧 46% 圖 圖 
肌 - 、 、 ： • _ • “ 
I b J . I • • I • . 
With steroid No steroid No steroid ionic 
nonionic nonionic  




Male Female Statistics (X2 test) 
T 3 .2 
^ I 
S 龙 
-o 2 Number % Number % Value df p-value 
2 I 
C/3 。 
^ o ^ ^ ^ i 0.002 
$ .2 6 ‘ 
^ § I 






^ c ^ ^ ^ 0 % i 0.325 
G > 
^ I 
Table 29 Frequency of immediate reactions vs gender for each contrast media and tabulated 
against status of steroid cover 
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Female patients who had steroid had more immediate reactions than males. Previous 
results (Figure 13, P.45) stated that female patients who had nonionic lopamiro had 
more immediate reactions. Due to the fact that more female patients than males had 
steroid, the cumulative effect explained the previous observation. 
Steroid Male Female Statistics (X^ test) 
covered Number % Number % Value df p-value 
^ I M 26.37 i 0.000 
Table 30 Patients who had steroid cover 
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Delayed reactions, gender and steroid cover 
p=0.235 
60% 
60% r —— 
64 
51�/o W p=0.020 
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Table 31 Frequency of delayed reactions vs gender for each contrast media and tabulated 
against status of steroid cover 
、 
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Previous results (Figure 14, P.47) showed that females had more delayed reactions to 
nonionic lopamiro, but was not shown here. There were two reasons for the change 
in pattern. 
First of all, the nonionic contrast medium group was divided into two: with steroid 
cover and without steroid cover. There might not be enough data to draw solid 
conclusions on the frequency of reactions. 
Secondly, patients who were steroid covered, and subsequently had nonionic 
lopamiro, had more delayed reactions (Fig. 29, P. 85). And there were significantly 
more female patients than males who had steroid (Table 30’ P.92). The latter two 
factors added together gave the initial (without dividing into steroid or no steroid 
groups) observation that females had more delayed reactions to nonionic lopamiro. 
、 
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7.6 Factors affecting prevalence of reactions to contrast media in intravenous 
urography 
Reviewing the above results, there seemed to be some factors constituted to 
frequency of either immediate or delayed reaciions and the patterns were different. 
The factors identified were patients' 
1. Gender 
2. Type of contrast media used 
3. Dose of contrast media (in terms of Doses 1,2, and 3 respectively), please refer 
to Methodology (Table 4, p. 16) 
4. Status of steroid cover 
5. Age 
Logistic regression was used to determine the degree and significance of these 
factors. 
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7.6.1 Factors affecting prevalence of immediate reactions 
For immediate reactions, the results were 
Variable B S . E . Wald d f S i g R ~ £xp(B) 
Sex 0 . 1 7 3 0 . 1 5 6 1 . 2 2 2 1 0.268 0.0000 V m ^ 
Age -0.016 0.00510.241 1 0.001 -0.0869 0 .983^ 
Steroid covered? 0.046 0.2030.052 1 0.8190 0.0000 1.047 
Contrast media 1.146 0.178 41.090 1 0 .0000.1893 3.146 
Dose 0 . 1 0 2 0 . 0 9 2 1 . 2 2 8 1 0.267 0.0000 1.108 
Table 32 Factors affecting prevalence of immediate reactions 
From the above, the age of patients and kind of contrast media (nonionic lopamiro or 
ionic Urovison) significantly affect the frequency of immediate reactions, while 
patients，gender, whether steroid covered, and dose of contrast media had no 
significant effect. 
Reactions were less frequent with increasing age, and more frequent when ionic 




7.6.2 Factors affecting prevalence of delayed reactions 
Results of logistic regression were 
Variable B S . E . Wald df Sig R E x p ( B ) 
Sw 0 . 3 7 6 0 . 1 5 6 5 . 8 1 0 1 0.015~~0.0606 1.457 
A ^ -0 .006~~0 .005MS i 0.0000 ^ ^ 
Steroid covered? -1.040 0.20824.981 1 0.000 -0.1488 J 5 3 ^ 
Contrast media 0.022 0.185 0.015 ‘ 1 0.9020.0000 1 .023^ 
Dose 0.009 0 .0930 .010 1 0.9190.0000 1 .009^ 
Table 33 Factors affecting prevalence of delayed reactions 
Therefore, patients' gender and patients who were deemed to need and had steroid 
cover had significant effect on the frequency of delayed reactions, while age, contrast 
media used, and dose had no significant effect. Female patients, and patients who 
were steroid covered, had more delayed reactions. This was consistent with the 
observations and discussions in 'Why were there more delayed reactions after 
injecting nonionic lopamiro?' (P.83). Nonionic lopamiro caused about the same 
delayed reactions as did ionic Urovison. The observation that more patients 
developed delayed reactions after injecting nonionic lopamiro was related to the fact 
that high risk patients (who were therefore steroid covered) had more delayed 
reactions, and all these patients had nonionic lopamiro. Also, there were significantly 
more females than males who were steroid covered (Table 30, P.92). 
Of course what this study cannot answer, and would be difficult to design an ethical 
experiment to answer, is the possibility whether or not the steroids aggravated the 
reactions. 
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7.6.3 The value of studying prevalence of contrast reactions 
The topic of contrast media reactions frequently concentrates on the more severe 
symptoms, and fatalities. In daily life, fortunately, such incidences are rare. On the 
other hand, mild reactions are very frequent (about 70%, or 558 out of 796 patients in 
this series). Understanding mild reactions are also important, because that may lead 
to discovering or devising methods of prevention. Pedersen (1996) commented that 
'The purpose of injecting radiographic contrast media is to attenuate X-rays and all 
other effects are regarded as adverse effects and should be avoided.'(51) All kinds of 
contrast media reactions, mild and severe, should be prevented. Knowledge of 
contrast media induced reactions caused by different agents, especially nonionic or 
ionic contrast media, is valuable. Bettmann wrote in 1988 that '...it is important to 
attempt to define the difference, between contrast media in all areas, both to help 
define current use and to help in the development of newer, even safer contrast media 
in the future.' (51) 
The trend that females showed lower tolerance level to contrast media dose was 
consistent with Lang's suggestion that a larger blood volume in males would dilute 
the same dose of contrast significantly more than the smaller volume in females. 
Given the average male weighed 65 Kg at 95 m! blood per kilogram this gives an 
average total blood volume of 6,175 ml for this series. For the females (average 56 
Kg with a blood volume of 67 ml per Kg body weight) this figure is 3,752 ml or 
almost 61% of the male. 
Even though dose were adjusted for body weight, in the average male and female the 
theoretical concentrations of mg Iodine per ml of blood for Iodine dose levels of 300， 
390 and 450 would have been 
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Dose 1 Dose 2 Dose 3 
Dose level (mg I/Kg) ^ 
Male (mg I/ml of blood) 3?[6 4 j l 4/M 
Female (mg I/ml of blood) 448 
Table 34 Iodine content in contrast media per unit blood volume for different gender 
This supports the proposition that the optimal dose concentration should be different 
for each gender. 
For intravenous urography, the dose to female patients should not exceed 300 
mgl/Kg of body weight, since a higher dose mignt increase the chance of reactions. 
The image quality obtained may not be the best achievable but would achieve an 
acceptable balance between film quality and reactions. For males it appears to be 
safe to give the upper end of the dose concentration scale, and maybe even higher 
concentrations would be tolerated. Improved film quality could be obtained, but there 
would be an increased cost for the additional contrast used. The results obtained in 
this study would suggest that males might tolerate dose levels of up to 550 ml/ Kg of 
body weight without significant additional reactions (5.82 mg I/ml of blood). 
Modem standards of good clinical practice dictate that patients should be made 
aware of possible inexpedient side effects. Patients can prepare themselves better e.g. 
« 
tiredness may interfere with driving or dealing with important business and other 
matters，as this effect often lasts into the next day. This effect was recorded by 155 
(19.5% of total) of the patients in this series and as it had interfered with the patients' 
ability to lead their normal life and carry out normal activities this cannot be 
dismissed as unimportant. 
In this series, patients who felt tired only but whose life was not interfered, were not 
100 
counted as having a delayed reaction. In the 155 patients that were recorded as 
having a reaction, some took a few hours' sleep on the afternoon of injection (all 
injections were made in the mornings). Most patients had to sleep for two to three 
hours, and normal activities like cooking the dinner, or attending to children, were 
hindered. Some patients felt so tired the next morning that they had to skip their daily 
morning exercises. Some patients could not go to work for one day, although there 
were even more patients who presented themselves at work, but felt too exhausted to 
function or concentrate properly. Unfortunately due to the design of this study, details 
of fatigue, e.g. the extent, duration, etc. were not included. It appeared to be very 
typical, though, that almost all patients who felt tired after contrast injection required 
bed rest. Also, the main complaint was tiredness of the eyes. 
The medical profession should be aware of possible side effects. The awareness by 
radiologists and clinicians of delayed effects is poor. Better information and 




7.7 Further studies 
Further studies are indicated to answer the following questions: 
1. What is the optimum dose for the male? 




1. The first hypothesis was females show a lower tolerance level than males when 
given the same amount of contrast medium. 
Conclusion: 
This was proven. 
2. The second hypothesis was females are more likely to suffer contrast reactions 
than males irrespective of dose. 
Conclusion: 
Females were more likely to suffer reactions than males at high dose 
levels. 
3. The third hypothesis was there is a difference in reactions between ionic and 
nonionic contrast media. 
Conclusion: 
Patterns of reactions are different witli diiTerent contrast media. The ionic 
medium caused significantly more immediate reactions than the nonionic 
medium. There was no significant difference between two kinds of contrast 
media with regard to delayed reactions. 
The observation that nonionic medium caused more delayed reactions was due 
to the fact that all high-risk patients, who had significantly more delayed 
reactions, had nonionic contrast media. 
Two Additional conclusions are: 
4. Nonionic medium caused significantly more immediate reactions in female 
. patients. Female patients suffered significantly more delayed reactions for both 
> 
kinds of contrast media. 
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These conclusions need to be further verified by obtaining larger samples. 
5. Major risk factors for immediate reactions were patients' age and type of 
contrast media used. Major risk factors for delayed reactions were the female 
gender and the need for steroid cover (previous contrast reactions, allergy and 
asthma). 
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8.1 Recommendations devised from the conclusions (Clinical implications) 
In clinical situations, the following recommendations are devised by the conclusions 
of this study: 
1. For female patients, 300 mgl/Kg of body weight (BW) of nonionic contrast 
media (292.5 mgl/Kg BW for ionic) is recommended. For male patients, 450 
mgl/Kg BW nonionic or 455 mgl/Kg BW for ionic can be used to enhance 
image quality, without increasing risk of reactions. 
2. The findings suggested the need to warn patients of the nature of delayed 
reactions of the frequency and type specific for the kind of contrast medium 
administered. Fatigue was the most common delayed reaction. Patients should 
be reminded to avoid activities for making important decision or that are 




9.1 Appendix 1: Steroid cover regime in Diagnostic Radiology & Organ 
Imaging Department, Prince of Wales Hospital 
9.1.1 Introduction 
1. Fatalities due to contrast media injection: about 1 in 40,000 and 100,000. 
2. Relvant studies: intravenous urography, computed tomography with contrast 
enhancement, venography, angiography 
3. Risk factors: 
> Known iodine allergy 
< 
> Previous serious contrast reactions (anaphylactic shock, severe 
bronchospasm, cardio-respiratory arrest) 
> Patient over 60 with heart disease 
> Patients with severe asthma, atopic eczema, hay fever, or allergic rhinitis 
(Source: Memo dated 17 January, 1994. Diagnostic Radiology & Organ Imaging 
Department, Prince of Wales Hospital, Hong Kong) 
V 
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9.1.2 Steroid cover regime for hypersensitive patients 
1. Adult . 
Cold cases 
Prednisolone oral: 
> 50 mg 6 hours for 24 hours before contrast injection 
> Then two doses of 50 mg 6 hourly after contrast injection 
Emergency cases 
> Hydrocortison 500 mg I.V. stat 
> Hydrocortison 500 mg I.V. in drip over 6 hours covering the study period 
> Hydrocortison 200 mg I.V. over next 12 hours 
2. Paediatric 
Prednisolone oral: 
> 0.5 mg/Kg 6 hourly for 24 hours before contrast injection 
> Then 0.5 mg/Kg 6 hourly for 12 hours after contrast injection 
Emergency cases 
> Hydrocortisone sodium succinate 4 mg/Kg intravenous stat before contrast 
injection 
> Then hydrocortisone sodium succinate 2 mg/Kg 6 hourly intravenous for 2 
doses after contrast injection 
(Source: Memo dated 17 January, 1994. Diagnostic Radiology & Organ Imaging 
Department, Prince of Wales Hospital, Hong Kong) 
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9.2 Appendix 2: Data sheet to record patient history 
The main risk factors of contrast media reactions are 
> Previous reactions to contrast media: the risk of the occurrence of reactions is 
roughly five times greater than the risk foi d picviously reaction-free group (21) 
> Age: reactions are more frequent for persons 20 - 50 years old, but most severe 
in older persons. Elderly patients are more susceptible to the chemotoxic effects 
of contrast media (4) 
> Allergy and asthma: at increased risk for idiosyncratic reactions (4) 
> Diabetes mellitus: there is high risk of contrast media induced conditions 
ranging from deterioration of kidney function to acute kidney failure (52). 
> Heart disease: death had been reported after contrast media injection. Heart 
failure might worsen due to the fluid overload of the intravascular space, 





To the patient attending intravenous contrast appointment, please answer the 
following questions: 
Q.l Have you had x-ray contrast media injection before (others than isotope 
scanning)? 
] N e v e r (Please go to Q.3) 
] 1 - 3 times (Please go to Q.2) 
Zl More than 3 times (Please go to Q.2) 




Q.3 Have you ever suffered from the following? (You may tick more than one 
answer). 
Zl Allergies (to seafood, drugs, etc.) sympto�c include 
D Skin rashes • Facial (include eyes and lips) swelling 
• Rhinitis � Sneezi^ 
_] Asthma ‘ 
• Heart disease 
] D i a b e t e s 
] N o n e of the above 
Q.4 Did your physician prescribe anti-allergic medication, such as steroid, for this 
exam? 、 
• ] Yes (Please go to Q.5) 
• No (End of questionnaire, thank you) ‘ 
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Q.5 Did you take your prescription as instructed? 
• Yes (Please go to Q.6 & 7) 
I ] Partly, I only took part of the medication (Please go to Q.6 & 7) 
• No (Please go to Q.7) 
Q.6 After taking the prescription, did you feel any side effects? 
_J No (End of questionnaire, thank you) 
• Yes (Please check below. You may take rn。怕 than one choice): 
• Warm flush O Headache | 口 Oedema 
• Taste in mouth • Dizzy 口 Vomiting 
• Skin rash • Vertigo • Nausea 
• Skin itchiness • Muscle weakness 口 Diarrhea 
• Shortness of breath • Convulsion, epileptic • Other gastrointestinal 
attack discomfort 
Other: 
Q-7 Please state the reason why you could not take the prescription as instructed? 
(End of questionnaire, thank you) 
、 
110 ‘ 
9.3 Appendix 3: Injection conditions and immediate reactions 
The second data sheet was roughly divided into three parts: 
1. Image quality score - please see Appendix 5, Quality control by comparators 
2. Injection records: 
> Whether the patient was steroid covered was assessed by the nurse and 
recorded as a reference of demographic data. In this series all patients who 
were covered had nonionic lopamiro. 
Steroid covered for Contrast media Statistics (X^ t e s t ) ^ 
this exam? lopamiro Urovison Value ~~d fP-va lue 
(Nonionic) (Ionic) 
^ M a l e ^ 1 0 0 % 
Female 100% 
No Male 42.1% ^ 5 7 . 9 % 0.27 1 0 . 5 9 8 
Female 44.2% 55.8% 
Table 35 Choice of contrast media in relationship to steroid cover 
> Females patients' LMPs were recorded to ensure that they were not pregnant. 
> The type and amount of contrast media was recorded. 
> Pre-injection blood pressure and pubc v/ere recorded, and at five minutes 
post-injection the measurements were repeated. 
3. Record of immediate reactions, and actions taken, if any 
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9.3.1 Immediate reactions 
Immediate reactions can be classified into physiochemotoxic and idiosyncratic. The 
characteristics and symptoms are listed below (9): 
Physiochemotoxic lldiosyncratic 
Dose related Not dose related 
Heat Severe hypotension 
Decreased renal function Convulsion ~ 
Paralysis / convulsion Bronchospasm - asthma 
Hypervolemia Pulmonary edema “ 
Strange taste in throat Dysp..oea - cyanosis — 
Arrhythmia Coma, respiratory arrest “ 
Nausea Angina, cardiac arrest 





Table 36 Classification of contrast media reactions 
Data from (1) Bush W. (1998). "Risk Factors, Prophylaxis and Therapy of X-Ray Contrast Media 
Reactions" in Advances in X-Ray Contrast Collected Papers. Dawson P. Clauss W. (eds.). 
Kluwer academic : Dordrecht. (2) Grainger R. (1983). "What Adverse Reactions can be Expected 
after Administration of Contrast Media?" in Contrast media in Practice. Dawson P. & ClauB W. 
(eds.) Springer-Verlag: Berl in.� 
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9.3.2 Patients' records of injection and immediate reactions 
Below is the data sheet of patients' injection records and record of immediate 
reactions. 
Image quality score of 12-minute film  
• 0 • 1 • 2 • 3 n ~ 4 n ~ 5 
Non-diagnostic Defined by comparator  
Pre-injection 
1. Steroid covered? • Yes • No 
2. LMP = DP MM YY 
口 Not applicable • Menopause • Hysterectomy done 
• Tubal legation done • Other (Please specify) 
3. Contrast injection ” 
Contrast media A m o u n t O r d e r e d by Checked by 
used 
• lopamiro 300 ‘ 
ml 
• Urovison 58% 
Additional contrast ~ n lopamiro 300 
used • Urovison 58% Injection time = 
am./p.m. 
4. Pre-contrast blood pressure: _mmHg 
5. Pulse just before injection: / min. 
Post injection 
6. Injection finished within 1 minute? • No • Yes 
7. 5 minutes post-contrast blood pressure: mmHg 
8. Reactions 
V 
• None (Must tick if no reaction, otherwise this record is invalid. Thanks.) 




口 Cough • Bronchospasm - asthma 
• Heat sensation • Coma 
• Itching • Convulsions 
• Nausea • Dyspnoea - cyanosis 
口 Rash (Urticaria) • Generalized urticaria 
• Strange taste in throat • Respiratory arrest 
• Vomit • Angina 
• Yawning &/or sneezing 
• Others (Please specify) 






• Others (Please specify)  
* 
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9.4 Appendix 4: Data sheet to record delayed reactions 
Davis (1998) wrote that 'Delayed reactions to urographic contrast medium are more 
common than acute reactions, often more unpleasant and some have been fatal. 
There are reports of effects on most organ systems.' (8) 
Delayed reactions are defined as reactions that occurred more than an hour after 
injection (33). There are a variety of delayed reactions. The most common reactions 
were all tabulated in alphabetical order in the questionnaire. They were arm pain, 
asthma, difficulty in urination, dizziness, fatigue, gastrointestinal upset, headache, 
itching, joint pain, swelling and/or of the salivary glands, rash, and heat sensation (on 
various parts of the body) (8). A separate column recorded if the patient had similar 
symptoms within one year, without contrast media injection. If the symptom 
subsided long before injection (may be less than one year), but recurred after 
injection, it was still counted as a reaction. In many cases, patients could tell whether 
the symptoms recurred after injection, or totally unrelated. Patients were not so sure 
for symptoms they encountered for the first time. 
If there were delayed reactions, whether the patients sought medical advice, and if 
any treatment was required were recorded. This information could be used as a 
measure of how unpleasant delayed reactions were. 
V 
115 
9.4.1 Questionnaire of delayed reactions 
Body height= cm Body weight = Kg 
Q1 Did you suffer from any discomfort after receiving contrast media? 
口 Yes, only after I left the radiology department (Go to Q.2) 
口 Yes, both immediately and after I left the radiology department (Go to Q.2) 
• Yes, only immediately (Go to Q.3) 
• No (Go to Q.3) 
Q2. When was the onset of delayed reactions? 
• On the same day of exam at about a.m./p.m. 
• O n _ D D _ M M _ _ Y Y at about a.m./p.m. 
Q3. Either immediately or after 1 hour post-injection, or in the past 12 months without 
contrast media, did you suffer from the following symptoms? 
Symptoms Time of onset~“ 
Immediately post- After 1 hour post- In the past 12 
injection injection months without 
contrast media 
1. Arm pain • ~‘ • • 
2. Asthmatic attack • • • 
Difficulty in • • • 
urination 
^ D i z z y • • • 
5. Fatigue • • • 
6. Gastrointestinal symptoms e.g. constipation, nausea, vomiting, diarrhea, etc 
• • • 
7. Headache • • • 
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^ I t c h i n g • • • 
9. Joint pain • • • 
10. Salivary gland pain/swelling 
• • • 
11. Rash • • • 
12. Heat sensation • • • 
13. Other (Please 
specify) 
Q4. Did you consult a doctor for any of the above 6yx.iplom(s)? 
口 Yes (Go to Q.5) • Due to injection • Unrelated to injection 
口 No (End of questionnaire, thank you) 
Q5. Did your doctor prescribe any medications for the symptom(s)? 
口 Yes (End of questionnaire, thank you) 
口 No (End of questionnaire, thank you) 
、 
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9.4.2 Notes on the questionnaire of delayed reactions 
1. In Q2, "When was the onset of delayed reactions?" the answers were 
Either "On the same day of exam at about a.m./p.m." 
Or "On DP MM YY at about a.m./p.m." 
The answers to this question recorded the time of onset of the first delayed 
symptom. They were entered into the database as date and time valuables. The 
answer minus injection time gave the time elapsed before onset of delayed 
symptoms. Time of injection was recorded in the sheet "Patients' records of 
injection and immediate reactions" on P. 113. 
2. There were four columns to the table in Q3. The first column listed all common 
symptoms of delayed reactions. The second to fourth column recorded presence 
or absence of each symptom, divided into different time frames. 
The second column recorded symptoms which onset was within one-hour post 
injection, which was regarded as immediate reactions. 
The third column recorded symptoms whicri onset was more than one-hour post 
injection, the delayed reactions. 
The fourth column recorded any symptoms that the patient experienced within 
twelve months prior injection. It was because some researchers excluded patients 
who had the same symptoms in the past one year without contact with the 
contrast medium (47). However, Dawson and Hemingway (1987) have suggested 
that some pre-existing disease, e.g. heart failure and renal failure, were 
aggravated by contrast media injections (20). During the course of this study, it 
was found that in many cases, patients could tell whether the symptoms had 
recurred after the injection, or were totally unrelated to the injection, and 
coincidental. Patients were not so sure for symptoms they encountered for the 
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first time whether these were due to the injection or not. 
Weighing the two contradicting viewpoints of other authors, plus the experience 
gained in the study, it was decided that symptoms that the patients never 
experienced before injection, as well as those they may have had before, but had 
already subsided long before injection (maybe less than 12 months), and that 
patients considered the contrast injection was responsible for the recurrence, were 
< 
included. Therefore, data obtained in this column were not integrated into the 
main text. A summary of the results is tabulated below. 
Symptoms Number of patients 
No symptom Yes Yes and also had the same 
symptom symptom before injection 
Number Number ~ N u m b e r % of Yes 
Fatigue ^ m 4 11 
Rash 703 % 3 ^ 
Itching m 100 15 15^ 
Gastrointestinal upset 681 106 9 ^ 
Joint pain 584 188 ^ 
Dizzy ^ ^ 4 ^ 
Headache 736 ~50 10 
Salivary gland swollen/pain 774 ^ 0 — 
H ^ f l i S 0 — 
Difficulty in urination 、 757 35 4 UA 
Shortness of breath 752 41 3 T3 
Arm pain 772 24 0 — 
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Table 37 Number of patients with or without delayed reactions 
Descriptions of the symptoms were not too specific. For example, a patient might 
have replied in the phone interview that he had joint pain after contrast injection. 
Also he responded that he had joint pain within a few months before the exam, 
but the pain was in different regions in both incidences. The record would still 
show that that particular patient had joint pain both before and after contrast 
injection. This case would have been excluded from other researchers' studies. In 
the current study, decision was made at Tioment of interview whether the 
symptom would be included as having a delayed reaction or not. 
3. Unfortunately due to the design of this study, details of fatigue, e.g. the extent, 
duration, etc. were not included. Throughout the study, the absence and presence 
of each symptom (immediate or delayed) were recorded and analyzed for their 
frequencies, and tested for significant differences between groups. 
V 
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9.5 Appendix 5: Quality control by comparators 
9.5.1 Comparators 
In this study, a set of comparators was employed to perform quality control. The 
reason for the need of film quality control was that the dose of contrast media 
affected opacification of IVU films, which in turn affected image quality. Contrast 
media dose had an effect on image quality (29). Since this project manipulated 
doses, it was essential to use some means of quality control to make sure everything 
was within reasonable limits. 
It has been suggested that the quality of the intravenous urography would be judged 
by the criteria "if it permitted perfect diagnostic evaluation with a contrast density in 
the urinary tract higher than the x-ray absorption of the bone of an approximately 30-
year old healthy person." (29) 
In practice, this statement is difficult to use for film quality assessment. Therefore, a 
set of comparators was constructed and used instead. In this project, 12-minute films 
were used to represent the quality of opacity caused by contrast media. 
、 
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9.5.2 Choice of films to represent the IVU exams 
Why 12-minute films were used 
Good/adequate opacification by lohexol 
100% r cnoA 
90% 90% 日d 而 
82O/o 
8 0 % - ~ 
S ^ 670/0 
•lite 
5 min. (n=15) 10 min. N=30) 20 min. (n=15) 
Average=68% Average=75% Average=82% 
Figure 33 Percentage off films with good or adequate opacification by nonionic lohexol 
Data source: Taenzer et. al. (1983) "Urography with Non-ionic Contrast Media: I. Diagnostic 
Quality and Tolerance of lohexol in Comparison with Meglumine Amidotrizoate" in Contrast 
Med/a in urography, angiography & CT. Taenzer V. Zeitler E. (eds.). Thieme-Stratton: NY. 
Figure 26 gave the percentage of good or adequate opacification using lohexol, a 
nonionic contrast medium. Opacification of renal parenchyma, pelvicalyceal system, 
and ureters are compared. On average, the 20-minute films gave the best images of the 
urinary system. However, pelivcalyceal opacification was similar for 5 to 20 minutes 
(90%, 90% and 93% respectively). 
In our department, we routinely take an AP view of the renal region immediately after 
injection of contrast medium, the zero minute film. A full-length kidney-ureter-
bladder (KUB) film is obtained at five minutes post injection, then abdominal 
compression is applied. It is our department protocol that at twelve minutes after 
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injection, an AP film of the renal areas is taken to demonstrate the collecting systems 
in a fully distended state (23). Then the abdominal compression may be released if 
no additional films are required. 
• 
In this study, although the 20-minute film best demonstrates quality of opacification, 
the 12-minute film was used for assessment. This was due to patient comfort and 
smooth patient throughput in our department. 
Abdominal compression was not applied to a small number of patients e.g. patients 
who had recent abdominal surgery, or patients with gross hydronephrosis. With these 
patients, the x-ray table was tilted head-down a few degrees, to obtain certain degree 
of distension of the collecting systems. Full distension might not be achieved, and 
subsequently the image quality scores would be diTected. However, the objective of 
quality control was to ensure reasonable image quality was obtained throughout the 
whole study, and this was proved to be true. 
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Good/adequate opacification by Urovist 
100%「 97% 
83% 
80% • 1-76% 76% 
70% ~ 72/« _ 
mm 
5 min. (n=15) 10 min. N=29) 20 min. (n=14) 
Average=52% Average=76% Average=82% 
Figure 34 Percentage of films with good or adequate opacification by ionic Urovist 
Data source: Taenzer et. al. (1983) "Urography with Non-ionic Contrast Media: I. Diagnostic 
Quality and Tolerance of lohexol in Comparison with Meglumine Amidotrizoate" in Contrast 
Media in urography, angiography & CT. Taenzer V. Zeitier E. (eds.). Thieme-Stratton: NY. 
Figure 34 showed the same entities when Urovist, an ionic contrast is used, showing 
similar opacification of parenchyma and ureters between 10 and 20-minute films 
although better opacification of the pelvicalyceal system (83% to 97%). 
、 
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Nephrogram not as ^ ^ ^ ^ ^ H f l Contrast density higher 
good as I B H r ^ i P I ^ ^ H Q I than attenuation of 
0 minute film • . 遍 X-ray by the spine 
mtlmm^M 
Fully distended 
system Proximal ureters 
Figure 35 Example of a 12-minute film with good contrast 
A 12-minute film with good contrast showed ftilly distended pelvicalyceal systems, 
with contrast density higher than attenuation of x-ray by the spine, and showed 
proximal ureters when compression was applied. The nephrogram was not as good 
as in 0-minute films. 
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9.5.3 The comparator system 
When using the comparators, only the degree of opacification of the pelvicalyceal 
I 
system was compared. Other factors which might constitute to the image, e.g. 
pathology, exposure factors, etc., were ignored. In case both sides did not show the 
same opacification, the better side was used for comparison. 
A film with contrast greater than that of the spine scored 5 marks. 
On the other end of the spectrum, a film that was non-diagnostic due to very poor 
opacification scored 0 marks. A film with poor contrast that was barely diagnostic 
scored 1 mark. A film with contrast much less the spine was below average (but still 
of some diagnostic value), and scored 2 marks. Two more grades towards the higher 
end were also defined as average, (contrast less than the spine, 3 marks), and good 
when the contrast was equal to the spine, 4 marks 
Once the comparator set was compiled, the assessor only needed to compare a film 
with the comparator set. Description was no longer needed. A set of comparators was 
viewed on the viewing box, side by side with a film on trial. The reader compared 
the trial film to the comparators. A score could be determined to be the same degree 
of opacification that matched best with the comparator. This method had an 
advantage that the trial films and comparator were viewed under the same viewing 
conditions, eliminating some inconsistencies. 
、 
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9.5.4 The comparator set 
Score Comparator Description 
Excellent. 
Contrast greater than that of the spine. 
• 
4 m n n • 
— 丽 = 
Adequate. 
— 丽 
2 Less than adequate. 
Contrast much less than the spine. 
A film with poor contrast that is barely 
diagnostic. 
0 No sample film No demonstration/ no diagnostic. 
Film quality is worse than score=l 
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9.5.5 How the comparator set was compiled 
Constructing a comparator set required that the comparators were representative of the 
range of categories encountered. Large number of films needed to be graded so that the 
representative range could be selected. 
The comparators must represent characteristics evenly in all grades to ensure grading 
accuracy and to avoid confusions. The characteristics must be obviously demonstrated 
and lay evenly between two categories. 
1 2 3 4 5 / 
I I I 0 
1 2 3 4 5 X ^ 
> 
Figure 36 Schematics showing construction of comparators 
9.5.6 Results of image quality using comparators 
Please see Results: Results of quality control and Discussion: Results of quality 
control (by comparators). 
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